<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis - Peinemann, F - 2020 | Cochrane Library</title> <meta content="Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis - Peinemann, F - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011941.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis - Peinemann, F - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011941.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011941.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis" name="citation_title"/> <meta content="Frank Peinemann" name="citation_author"/> <meta content="Children's Hospital, University of Cologne" name="citation_author_institution"/> <meta content="pubmedprjournal@gmail.com" name="citation_author_email"/> <meta content="Marco Harari" name="citation_author"/> <meta content="Dead-Sea and Arava Science Center, Dead Sea Branch" name="citation_author_institution"/> <meta content="Sandra Peternel" name="citation_author"/> <meta content="Thalia Chan" name="citation_author"/> <meta content="King's College London" name="citation_author_institution"/> <meta content="David Chan" name="citation_author"/> <meta content="The University of Nottingham" name="citation_author_institution"/> <meta content="Alexander M Labeit" name="citation_author"/> <meta content="National University of Singapore" name="citation_author_institution"/> <meta content="Thilo Gambichler" name="citation_author"/> <meta content="Ruhr-Universität Bochum" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD011941.pub2" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/05/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011941.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011941.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011941.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Baths [adverse effects, *methods]; Chronic Disease; Combined Modality Therapy [adverse effects, methods]; Ficusin [therapeutic use]; Mineral Waters [adverse effects, *therapeutic use]; Photosensitizing Agents [therapeutic use]; Psoriasis [*therapy]; PUVA Therapy [methods]; Randomized Controlled Trials as Topic; Sodium Chloride [therapeutic use]; Ultraviolet Therapy [adverse effects, *methods]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011941.pub2&amp;doi=10.1002/14651858.CD011941.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="UiM8QuvV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011941\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011941\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","th","ms","fa","pl","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011941.pub2",title:"Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis",firstPublishedDate:"May 5, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Skin Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UiM8QuvV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011941.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011941.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011941.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011941.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011941.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011941.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011941.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011941.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011941.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011941.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3852 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011941.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-sec-0141"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-sec-0026"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-sec-0027"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-sec-0135"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/appendices#CD011941-sec-0146"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/supinfo/CD011941StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/supinfo/CD011941StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/information#CD011941-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Frank Peinemann</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/information#CD011941-cr-0005">Marco Harari</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/information#CD011941-cr-0006">Sandra Peternel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/information#CD011941-cr-0007">Thalia Chan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/information#CD011941-cr-0008">David Chan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/information#CD011941-cr-0009">Alexander M Labeit</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011941.pub2/information#CD011941-cr-0010">Thilo Gambichler</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/information/en#CD011941-sec-0156">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 May 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011941.pub2">https://doi.org/10.1002/14651858.CD011941.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011941-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011941-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011941-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011941-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011941-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD011941-abs-0005">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011941-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011941-abs-0001" lang="en"> <section id="CD011941-sec-0001"> <h3 class="title" id="CD011941-sec-0001">Background</h3> <p>Chronic plaque psoriasis is an immune‐mediated, chronic, inflammatory skin disease, which can impair quality of life and social interaction. Disease severity can be classified by the psoriasis area and severity index (PASI) score ranging from 0 to 72 points. Indoor artificial salt bath with or without artificial ultraviolet B (UVB) light is used to treat psoriasis, simulating sea bathing and sunlight exposure; however, the evidence base needs clear evaluation. </p> </section> <section id="CD011941-sec-0002"> <h3 class="title" id="CD011941-sec-0002">Objectives</h3> <p>To assess the effects of indoor (artificial) salt water baths followed by exposure to artificial UVB for treating chronic plaque psoriasis in adults. </p> </section> <section id="CD011941-sec-0003"> <h3 class="title" id="CD011941-sec-0003">Search methods</h3> <p>We searched the following databases up to June 2019: the Cochrane Skin Group Specialised Register, CENTRAL, MEDLINE, Embase, and LILACS. We also searched five trial registers, and checked the reference lists of included studies, recent reviews, and relevant papers for further references to relevant trials. </p> </section> <section id="CD011941-sec-0004"> <h3 class="title" id="CD011941-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) of salt bath indoors followed by exposure to artificial UVB in adults who have been diagnosed with chronic plaque type psoriasis. We included studies reporting between‐participant data and within‐participant data. We evaluated two different comparisons: 1) salt bath + UVB versus other treatment without UVB; eligible comparators were exposure to psoralen bath, psoralen bath + artificial ultraviolet A UVA) light, topical treatment, systemic treatment, or placebo, and 2) salt bath + UVB versus other treatment + UVB or UVB only; eligible comparators were exposure to bath containing other compositions or concentrations + UVB or UVB only. </p> </section> <section id="CD011941-sec-0005"> <h3 class="title" id="CD011941-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane. We used GRADE to assess the certainty of the evidence. </p> <p>The primary efficacy outcome was PASI‐75, to detect people with a 75% or more reduction in PASI score from baseline. The primary adverse outcome was treatment‐related adverse events requiring withdrawal. For the dichotomous variables PASI‐75 and treatment‐related adverse events requiring withdrawal, we estimated the proportion of events among the assessed participants. </p> <p>The secondary outcomes were health‐related quality of life using the Dermatology Life Quality Index, (DLQI) pruritus severity measured using a visual analogue scale, time to relapse, and secondary malignancies. </p> </section> <section id="CD011941-sec-0006"> <h3 class="title" id="CD011941-sec-0006">Main results</h3> <p>We included eight RCTs: six reported between‐participant data (2035 participants; 1908 analysed), and two reported within‐participant data (70 participants, 68 analysed; 140 limbs; 136 analysed). One study reported data for the comparison salt bath with UVB versus other treatment without UVB; and eight studies reported data for salt bath with UVB versus other treatment with UVB or UVB only. Of these eight studies, only five reported any of our pre‐specified outcomes and assessed the comparison of salt bath with UVB versus UVB only. The one included trial that assessed salt bath plus UVB versus other treatment without UVB (psoralen bath + UVA) did not report any of our primary outcomes. The mean age of the participants ranged from 41 to 50 years of age in 75% of the studies. None of the included studies reported on the predefined secondary outcomes of this review. We judged seven of the eight studies as at high risk of bias in at least one domain, most commonly performance bias. Total trial duration ranged between at least two months and up to 13 months. </p> <p>In five studies, the median participant PASI score at baseline ranged from 15 to 18 and was balanced between treatment arms. Three studies did not report PASI score. Most studies were conducted in Germany; all were set in Europe. Half of the studies were multi‐centred (set in spa centres or outpatient clinics); half were set in a single centre in either an unspecified settings, a psoriasis daycare centre, or a spa centre. Commercial spa or salt companies sponsored three of eight studies, health insurance companies funded another, the association of dermatologists funded another, and three did not report on funding. </p> <p>When comparing salt bath plus UVB versus UVB only, two between‐participant studies found that salt bath plus UVB may improve psoriasis when measured using PASI 75 (achieving a 75% or more reduction in PASI score from baseline) (risk ratio (RR) 1.71, 95% confidence interval (CI) 1.24 to 2.35; 278 participants; low‐certainty evidence). Assessment was conducted at the end of treatment, which was equivalent to six to eight weeks after start of treatment. The two trials which contributed data for the primary efficacy outcome were conducted by the same group, and did not blind outcome assessors. The German Spas Association funded one of the trials and the funding source was not stated for the other trial. </p> <p>Two other between‐participant studies found salt bath plus UVB may make little to no difference to outcome treatment‐related adverse events requiring withdrawal compared with UVB only (RR 0.96, 95% CI 0.35 to 2.64; 404 participants; low‐certainty evidence). One of the studies reported adverse events, but did not specify the type of events; the other study reported skin irritation. One within‐participant study found similar results, with one participant reporting severe itch immediately after Dead Sea salt soak in the salt bath and UVB group and two instances of inadequate response to phototherapy and conversion to psoralen bath + UVA reported in the UVB only group (low‐certainty evidence). </p> </section> <section id="CD011941-sec-0007"> <h3 class="title" id="CD011941-sec-0007">Authors' conclusions</h3> <p>Salt bath with artificial ultraviolet B (UVB) light may improve psoriasis in people with chronic plaque psoriasis compared with UVB light treatment alone, and there may be no difference in the occurrence of treatment‐related adverse events requiring withdrawal. Both results are based on data from a limited number of studies, which provided low‐certainty evidence, so we cannot draw any clear conclusions. </p> <p>The reporting of our pre‐specified outcomes was either non‐existent or limited, with a maximum of two studies reporting a given outcome. </p> <p>The same group conducted the two trials which contributed data for the primary efficacy outcome, and the German Spas Association funded one of these trials. We recommend further RCTs that assess PASI‐75, with detailed reporting of the outcome and time point, as well as treatment‐related adverse events. Risk of bias was an issue; future studies should ensure blinding of outcome assessors and full reporting. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011941-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011941-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011941-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011941-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011941-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011941-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD011941-abs-0010">Polski</a> </li> <li class="section-language"> <a class="" href="full/th#CD011941-abs-0006">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011941-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011941-abs-0002" lang="en"> <h3>Indoor bathing in salt water followed by exposure to artificial ultraviolet B light for chronic plaque psoriasis </h3> <p><b>Review question</b> </p> <p>We reviewed the evidence about the effect of indoor bathing in salt water for adults with chronic plaque psoriasis followed by artificial ultraviolet B (UVB) light treatment. We evaluated two different comparisons: 1) Salt bath with UVB versus other treatment without UVB; eligible comparators were exposure to psoralen bath, psoralen bath + artificial ultraviolet A (UVA) light, topical treatment, systemic treatment (oral or injected medicines that work throughout the entire body), or placebo (an inactive substance). 2) Salt bath with UVB versus other treatment with UVB or UVB only; eligible comparators were exposure to bath containing other compositions or concentrations + UVB or UVB only. The degree of severity of psoriasis can be measured by the psoriasis area and severity index (PASI). Improvement can be indicated by a reduction of PASI. We requested at least a 75% reduction in PASI‐75 score to evaluate a potential beneficial effect. To evaluate a potential harmful effect, we chose treatment‐related side effects severe enough to stop treatment. </p> <p><b>Background</b> </p> <p>Chronic plaque psoriasis is a skin disease characterised by red‐coloured lesions with silvery scales. Bathing in the Dead Sea and exposure to the sun may improve the lesions but may not be practical for most patients. Artificial salt bath and exposure to UVB could simulate the natural exposure. </p> <p><b>Study characteristics</b> </p> <p>The evidence is current to June 2019. We included eight trials (1976 analysed participants). One included trial assessed salt bath plus UVB versus other treatment without UVB (psoralen bath + UVA), but it did not report our primary outcomes for this comparison. Eight trials assessed our second comparison of interest: salt bath with UVB versus other treatment with UVB or UVB only, and those that reported any outcomes of interest (only five studies) specifically compared salt bath with UVB versus UVB only. </p> <p>No study reported our secondary outcomes. The duration of trials in total ranged between at least two months and up to 13 months. Outcomes were assessed at the end of treatment. </p> <p>We analysed trials in which different treatments were applied to different participants, and we separately analysed trials in which different treatments were applied to the same participant, but to different body parts. Participants were male or female, and their ages mostly ranged from 41 to 50 years. In five studies, the median PASI score at baseline ranged from 15 to 18 and was balanced between treatment arms. Three studies did not report PASI score. Three studies were sponsored by commercial spa or salt companies, one by health insurance companies, one by an association of dermatologists, and three did not report on funding. Half of the studies were conducted in multiple centres; the remainder were conducted in single centres. Most of the studies were conducted in Germany; all were based in Europe. </p> <p><b>Key results</b> </p> <p>No study reported primary outcome data for the comparison salt bath with UVB versus other treatment without UVB; five studies reported primary outcome data for salt bath with UVB versus UVB only. With respect to achieving PASI‐75, the pooled data of two studies indicated that salt bath + UVB may reduce psoriasis severity compared to UVB only (low‐certainty evidence); however, these two studies were conducted by the same group, and the German Spas Association funded one of the trials (the other trial did not report any funding source). Neither of the studies hid the treatment allocation from the outcome assessors. </p> <p>When assessing treatment‐related adverse events requiring withdrawal, data from three other studies showed there may be little to no difference between salt bath plus UVB and the comparator UVB only (low‐certainty evidence). The adverse events included skin irritation and severe itch immediately after Dead Sea salt soaks (salt bath + UVB group), and inadequate response to phototherapy and conversion to psoralen bath + UVA (UVB only group). </p> <p><b>Certainty of the evidence</b> </p> <p>We judged the evidence for ‘PASI‐75’ and ‘treatment‐related adverse events requiring withdrawal’ as low certainty. Our confidence was affected by limitations, such as risk of bias (examples being inadequate blinding and high probability of publication bias). The reporting of our outcomes was non‐existent or limited. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011941-sec-0141" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011941-sec-0141"></div> <h3 class="title" id="CD011941-sec-0142">Implications for practice</h3> <section id="CD011941-sec-0142"> <p>Low‐certainty evidence indicates that people with chronic plaque psoriasis may see a reduction in psoriasis severity after treatment with indoor salt bath + ultraviolet B light (UVB) compared against UVB alone. </p> <p>Low‐certainty evidence for the same comparison indicates that people with chronic plaque psoriasis may experience little to no difference in risk of treatment‐related adverse events requiring withdrawal. </p> <p>As the evidence is based on data from a limited number of studies, which provided low‐certainty evidence, we cannot draw a clear conclusion regarding the benefit or harm of indoor (artificial) salt water baths followed by exposure to artificial UVB for treating chronic plaque psoriasis in adults. The two trials which contributed data for the primary efficacy outcome were conducted by the same group, and one of the two trials was funded by the German Spas Association, although the other trial did not report any funding source. Neither trial blinded the outcome assessors. </p> <p>Of our two comparisons of interest, one (Indoor salt bath + UVB versus other treatment without UVB) was assessed by a single study, which did not report any of our pre‐specified outcomes. The other comparison (Indoor salt bath + UVB versus other treatment + UVB or UVB only) was assessed by all eight included studies, but their reporting of our pre‐specified outcomes was either non‐existent or limited, with a maximum of two studies reporting a given outcome. </p> </section> <h3 class="title" id="CD011941-sec-0143">Implications for research</h3> <section id="CD011941-sec-0143"> <p>We recommend further randomised controlled trials (RCTs) that assess Psoriasis Area and Severity Index (PASI‐75), with detailed reporting of the outcome, as well as treatment‐related adverse events requiring withdrawal. Future studies should be independently funded, and should ensure blinding of assessment and should enable blinding of performance. The time points of assessing any outcome should be specified. We think that 'end of treatment' might not be sufficiently clear. Several time points should be used to allow matching with other studies. The number of people or limbs available for analysis should be given for every time point. The included studies lacked data on all secondary outcomes. These outcomes should be considered in future studies. </p> <p>The limited number of trials and centres suggest a need for increased generalisability in the evidence base for this treatment. Future studies should consider potential harm by UVB exposure. Thus, it is important to keep contact with patients, general practitioners, and dermatologists and inform about the well‐being of the participants on a regular basis. In this context it seems meaningful to develop core outcomes for psoriasis treatment trials through the Cochrane Skin <b>C</b> ore <b>Ou</b> tcome <b>S</b> et <b>In</b>itiative (CS‐COUSIN; <a href="http://cs-cousin.org" target="_blank">http://cs-cousin.org</a>). To consider any potential harm by UVB exposure, future study protocols should include long‐term observations. Future studies should clarify the reporting according to the CONSORT statement (<a href="./references#CD011941-bbs2-0085" title="SchulzKF , AltmanDG , MoherD , CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLOS Medicine2010;7(3):e1000251. [PMID: 20352064]">Schulz 2010</a>). </p> <p>Future comparisons should include less logistically‐complicated types of phototherapy, such as oral psoralen plus UVA (PUVA). Secondary malignancies are uncommon, and differences very unlikely to be detected in future RCTs. Observational studies are more likely to provide evidence on this topic. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011941-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011941-sec-0008"></div> <div class="table" id="CD011941-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Salt bath + UVB compared with UVB alone for chronic plaque psoriasis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Salt bath + UVB compared with UVB alone for chronic plaque psoriasis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients with chronic plaque psoriasis<br/><b>Setting:</b> indoor clinic or spa<br/><b>Intervention:</b> salt bath + UVB<br/><b>Comparison:</b> UVB alone </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks (95% CI)*</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect</b> <br/><b>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Number of participants</b> <br/><b>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of evidence</b> <br/><b>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk<sup>c</sup> </b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>PASI‐75 (number of participants with event) 6 to 8 weeks after start of treatment</b> </p> </th> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.71</p> <p>(1.24 to 2.35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>278</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The event was defined as achieving a 75% or more reduction in PASI score from baseline.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>285 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>487 per 1000</p> <p>(353 to 669)</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Treatment‐related adverse events requiring withdrawal (number of participants withdrawing) 3 to 8 weeks after the start of treatment<sup>d</sup> </b> </p> </th> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.96 (0.35 to 2.64)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>404</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The event was defined as dropping out of the study because of treatment‐related complications.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34 per 1000</p> <p>(12 to 92)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>PASI:</b> Psoriasis Area and Severity Index. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> We downgraded the certainty of evidence by two levels for this outcome. We downgraded one level because of study limitations (risk of bias). Due to lack of blinding, we judged a high bias of performance bias. We downgraded one level because of high probability of publication bias. The only two between‐participant studies that did contribute data on salt bath + UVB versus UVB alone (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>) to this outcome were conducted by the same sponsor. </p> <p><sup>b</sup> We downgraded the certainty of evidence by two levels for this outcome. We downgraded one level because of study limitations (risk of bias). Due to lack of blinding, we judged a high risk of performance bias. We downgraded one level because of high probability of publication bias. There were only two between‐participant studies (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>) that contributed data on salt bath + UVB versus UVB alone to this outcome. </p> <p><sup>c</sup> The assumed risk is based on the mean number of events across the control groups. Calculation regarding PASI‐75 response: Number of events: 22 + 14 = 36, total number of participants: 66 + 60 = 126, risk per 1000: 36 / 126 * 1000 = 285. </p> <p><sup>d</sup> Two between‐participant studies (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>, <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>) reported seven events with salt bath + UVB and seven events with UVB only. One additional within‐participant study (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>) reported one event with salt bath + UVB and two events with UVB only. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011941-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011941-sec-0009"></div> <section id="CD011941-sec-0010"> <h3 class="title" id="CD011941-sec-0010">Description of the condition</h3> <section id="CD011941-sec-0011"> <h4 class="title">Prevalence</h4> <p>Psoriasis is a multifactorial, immune‐mediated chronic inflammatory skin disease (<a href="./references#CD011941-bbs2-0069" title="NestleFO , KaplanDH , BarkerJ . Psoriasis. New England Journal of Medicine2009;361(5):496-509. [PMID: 19641206]">Nestle 2009</a>), affecting roughly 2% of the world population (<a href="./references#CD011941-bbs2-0033" title="ChristophersE . Psoriasis--epidemiology and clinical spectrum. Clinical &amp; Experimental Dermatology2001;26(4):314-20. [PMID: 11422182]">Christophers 2001</a>). In population‐based surveys, the prevalence of psoriasis is 2.2% in the continental USA (<a href="./references#CD011941-bbs2-0090" title="SternRS , NijstenT , FeldmanSR , MargolisDJ , RolstadT . Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. Journal of Investigative Dermatology. Symposium Proceedings2004;9(2):136-9. [PMID: 15083780 ]">Stern 2004</a>), and it is 1.5% in the UK (<a href="./references#CD011941-bbs2-0046" title="GelfandJM , WeinsteinR , PorterSB , NeimannAL , BerlinJA , MargolisDJ . Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Archives of Dermatology2005;141(12):1537-41. [PMID: 16365254]">Gelfand 2005</a>). In adults, prevalence ranges from 0.9% to 8.5% and incidence ranges from 78.9 to 230 per 100,000 person‐years on a global scale (<a href="./references#CD011941-bbs2-0073" title="ParisiR , SymmonsDP , GriffithsCE , AshcroftDM , Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. Journal of Investigative Dermatology2013;133(2):377-85. [PMID: 23014338]">Parisi 2013</a>). The occurrence of psoriasis increases with age and with distance of geographic regions from the equator; there is no clear difference in the prevalence between men and women (<a href="./references#CD011941-bbs2-0073" title="ParisiR , SymmonsDP , GriffithsCE , AshcroftDM , Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. Journal of Investigative Dermatology2013;133(2):377-85. [PMID: 23014338]">Parisi 2013</a>). </p> </section> <section id="CD011941-sec-0012"> <h4 class="title">Clinical signs and course</h4> <p>Clinically, chronic plaque psoriasis, which is also known as psoriasis vulgaris, is the most common type of psoriasis, affecting 80% to 90% of people with psoriasis (<a href="./references#CD011941-bbs2-0048" title="GriffithsCE , BarkerJN . Pathogenesis and clinical features of psoriasis. Lancet2007;370(9583):263-71. [PMID: 17658397]">Griffiths 2007</a>; <a href="./references#CD011941-bbs2-0060" title="LebwohlM . Psoriasis. Lancet2003;361(9364):1197–204. [PMID: 12686053]">Lebwohl 2003</a>). It is characterised by easily defined red‐coloured lesions (<a href="./references#CD011941-bbs2-0069" title="NestleFO , KaplanDH , BarkerJ . Psoriasis. New England Journal of Medicine2009;361(5):496-509. [PMID: 19641206]">Nestle 2009</a>). The plaques are a result of an inflammatory and hyperproliferative (growing faster than usual) epidermis (<a href="./references#CD011941-bbs2-0069" title="NestleFO , KaplanDH , BarkerJ . Psoriasis. New England Journal of Medicine2009;361(5):496-509. [PMID: 19641206]">Nestle 2009</a>). They are typically found on the outer sides of the elbow and knee joints as well as on the scalp and back. A genetic predisposition may be the most important basis for an onset of psoriasis (<a href="./references#CD011941-bbs2-0069" title="NestleFO , KaplanDH , BarkerJ . Psoriasis. New England Journal of Medicine2009;361(5):496-509. [PMID: 19641206]">Nestle 2009</a>). A dysregulated immune system may explain the pathogenesis of inflammation and keratinocyte activation and proliferation (<a href="./references#CD011941-bbs2-0069" title="NestleFO , KaplanDH , BarkerJ . Psoriasis. New England Journal of Medicine2009;361(5):496-509. [PMID: 19641206]">Nestle 2009</a>). The disease severity can change with time, sometimes with long periods of calm and sometimes with severe exacerbation (<a href="./references#CD011941-bbs2-0073" title="ParisiR , SymmonsDP , GriffithsCE , AshcroftDM , Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. Journal of Investigative Dermatology2013;133(2):377-85. [PMID: 23014338]">Parisi 2013</a>), with or without recognised trigger factors, such as infection and other environmental factors as referred to in section 'Risk factors' in <a href="#CD011941-sec-0010">Description of the condition</a>. The extent of the affected body surface area may be used to classify the severity as mild (less than 5%), moderate (5% to 10%), or severe (greater than 10%) (<a href="./references#CD011941-bbs2-0065" title="MenterA , GriffithsCE . Current and future management of psoriasis. Lancet2007;370(9583):272–84. [PMID: 17658398]">Menter 2007</a>). Henseler suggested two forms of nonpustular psoriasis: the early onset form was associated with familial inheritance, and the late onset form occurred predominantly sporadically (<a href="./references#CD011941-bbs2-0053" title="HenselerT , ChristophersE . Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. Journal of the American Academy of Dermatology1985;13(3):450-6. [PMID: 4056119]">Henseler 1985</a>). </p> </section> <section id="CD011941-sec-0013"> <h4 class="title">Symptoms</h4> <p>The main symptoms are itching and pain associated with uncomfortable scaling as a result of loss of cells from the epidermal layer of the skin (<a href="./references#CD011941-bbs2-0063" title="MartinML , GordonK , PintoL , BushnellDM , ChauD , ViswanathanHN . The experience of pain and redness in patients with moderate to severe plaque psoriasis. Journal of Dermatological Treatment2015;26(5):401-5.">Martin 2015</a>). </p> </section> <section id="CD011941-sec-0014"> <h4 class="title">Diagnosis</h4> <p>A medical doctor can suspect the diagnosis on the appearance of the skin and a dermatologist may confirm the diagnosis. Scaly and erythematous plaques that may be painful and itching are typical skin characteristics (<a href="./references#CD011941-bbs2-0069" title="NestleFO , KaplanDH , BarkerJ . Psoriasis. New England Journal of Medicine2009;361(5):496-509. [PMID: 19641206]">Nestle 2009</a>). A skin biopsy may be helpful to clarify the clinical diagnosis. </p> </section> <section id="CD011941-sec-0015"> <h4 class="title">Prognosis</h4> <p>The majority of patients experience mild skin lesions (<a href="./references#CD011941-bbs2-0069" title="NestleFO , KaplanDH , BarkerJ . Psoriasis. New England Journal of Medicine2009;361(5):496-509. [PMID: 19641206]">Nestle 2009</a>). Severe lesions may impair quality of life and social interaction. </p> </section> <section id="CD011941-sec-0016"> <h4 class="title">Severity indices</h4> <section id="CD011941-sec-0017"> <h5 class="title">Physician‐reported severity indices</h5> <p><a href="./references#CD011941-bbs2-0041" title="FredrikssonT , PetterssonU . Severe psoriasis--oral therapy with a new retinoid. Dermatologica1978;157(4):238-44. [PMID: 357213]">Fredriksson 1978</a> developed the Psoriasis Area and Severity Index (PASI). It is a measure of average redness, thickness, and scaliness of skin lesions weighted by the area of involvement. <a href="#CD011941-tbl-0002">Table 1</a> displays characteristics of the PASI. Response to therapy may be assessed by the percentage of people who have achieved a 75% or more reduction in their PASI score from baseline, which is referred to as PASI‐75. Itching is a substantial symptom of psoriasis, which may be assessed by a visual analogue scale (VAS) from 0 ('no itching') to 100 ('severe itching') as proposed by <a href="./references#CD011941-bbs2-0099" title="ZhuB , Edson-HerediaE , GuoJ , Maeda-ChubachiT , ShenW , KimballAB . Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial. British Journal of Dermatology2014;171(5):1215-9. [PMID: 24749812]">Zhu 2014</a>. </p> <div class="table" id="CD011941-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Psoriasis Area and Severity Index (PASI)</span></div> <tbody> <tr> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Section</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Area involved</b> </p> </th> <th align="center" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Severity</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Item</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Factor</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Item</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Factor</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Item</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Clinical signs</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Factor</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Head</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0, 1, 2, 3, 4, 5, or 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sum of clinical signs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Erythema (redness)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0, 1, 2, 3, or 4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 10%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Induration (thickness)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0, 1, 2, 3, or 4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10% to &lt; 30%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Desquamation (scaling)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0, 1, 2, 3, or 4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30% to &lt; 50%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50% to &lt; 70%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70% to &lt; 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90% to 100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Arms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trunk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Legs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Subtotal</p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Section factor *area factor* sum of clinical signs factor</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Sum of subtotals; range 0 to 72</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>According to <a href="./references#CD011941-bbs2-0041" title="FredrikssonT , PetterssonU . Severe psoriasis--oral therapy with a new retinoid. Dermatologica1978;157(4):238-44. [PMID: 357213]">Fredriksson 1978</a>. Online calculator available (<a href="./references#CD011941-bbs2-0035" title="CortiM , CortiM . Psoriasis Area Severity Index (PASI) Calculator (1.7.1) 2009. pasi.corti.li (accessed 22 July 2014).">Corti 2009</a>). Instructions: multiply section factor with area involved factor and multiply with sum of clinical signs factor; repeat for all four sections and add up all four subtotals. The items and corresponding factors regarding the area involved and the severity are exemplified for the section item 'head' and are not shown for the other section items 'arms', 'trunk', and 'legs'. Severity of clinical signs range from none (zero) to maximum (four). </p> </div> </div> </section> <section id="CD011941-sec-0018"> <h5 class="title">Patient‐reported severity indices</h5> <p><a href="./references#CD011941-bbs2-0039" title="FinlayAY , KhanGK . Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clinical &amp; Experimental Dermatology1994;19(3):210-6. [PMID: 8033378]">Finlay 1994</a> developed the Dermatology Life Quality Index (DLQI). The following website provides further information and interpretation: <a href="http://www.dermatology.org.uk/quality/quality-life.html" target="_blank">www.dermatology.org.uk</a>. The aim of this questionnaire is to measure how much the skin problem of a person has affected his or her life over the previous week (see <a href="#CD011941-tbl-0003">Table 2</a>). </p> <div class="table" id="CD011941-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Dermatology Life Quality Index (DLQI) questionnaire</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Question</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Answer options</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how itchy, sore, painful, or stinging has your skin been?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how embarrassed or self‐conscious have you been because of your skin? </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how much has your skin interfered with you going shopping or looking after your home or garden? </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> <p>Not relevant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how much has your skin influenced the clothes you wear?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> <p>Not relevant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how much has your skin affected any social or leisure activities?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> <p>Not relevant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how much has your skin made it difficult for you to do any sport?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> <p>Not relevant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, has your skin prevented you from working or studying?</p> <p>(If "No", over the last week, how much has your skin been a problem at work or studying?)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> <p>No</p> <p>Not relevant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how much has your skin created problems with your partner or any of your close friends? </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> <p>Not relevant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how much has your skin caused any sexual difficulties?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> <p>Not relevant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how much of a problem has the treatment for your skin been, for example, by making your home messy or by taking up time? </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> <p>Not relevant</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>The aim of the Dermatology Life Quality Index (DLQI) questionnaire is to measure how much the life of adults has been affected by their skin problem over the last week. The DLQI is calculated by summing the score of each question, resulting in a maximum of 30 and a minimum of zero. The higher the score, the more quality of life is impaired. The scoring of each question is as follows: Very much (three), A lot (two), A little (one), Not at all (zero), Not relevant (zero); question seven = Yes (three) to unanswered (zero). </p> <p>Meaning of the total DLQI score: zero to one = no effect at all on patient's life; two to five = small effect on patient's life; six to 10 = moderate effect on patient's life; 11 to 20 = very large effect on patient's life; 21 to 30 = extremely large effect on patient's life. Minimal Clinically Important Difference (MCID) of the DLQI: a change in DLQI score of at least four points is considered clinically important (<a href="./references#CD011941-bbs2-0029" title="BasraMK , FenechR , GattRM , SalekMS , FinlayAY . The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. British Journal of Dermatology2008;159(5):997-1035. [PMID: 18795920]">Basra 2008</a>). </p> <p><a href="./references#CD011941-bbs2-0039" title="FinlayAY , KhanGK . Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clinical &amp; Experimental Dermatology1994;19(3):210-6. [PMID: 8033378]">Finlay 1994</a> developed the DLQI. The following website provides further information and interpretation: <a href="http://www.dermatology.org.uk/quality/quality-life.html" target="_blank">www.dermatology.org.uk</a>. </p> </div> </div> </section> </section> <section id="CD011941-sec-0019"> <h4 class="title">Risk factors</h4> <p>The process by which psoriasis arises is not fully understood. Population, family, and twin studies have shown a genetic contribution to psoriasis (<a href="./references#CD011941-bbs2-0048" title="GriffithsCE , BarkerJN . Pathogenesis and clinical features of psoriasis. Lancet2007;370(9583):263-71. [PMID: 17658397]">Griffiths 2007</a>; <a href="./references#CD011941-bbs2-0062" title="LønnbergAS , SkovL , SkyttheA , KyvikKO , PedersenOB , ThomsenSF . Heritability of psoriasis in a large twin sample. British Journal of Dermatology2013;169(2):412-6. [PMID: 23574549]">Lønnberg 2013</a>; <a href="./references#CD011941-bbs2-0078" title="RahmanP , ElderJT . Genetic epidemiology of psoriasis and psoriatic arthritis. Annals of the Rheumatic Diseases2005;64(Suppl 2):ii37-9. [PMID: 15708933]">Rahman 2005</a>), which includes the association of psoriasis with certain human leukocyte antigen (HLA) alleles (<a href="./references#CD011941-bbs2-0049" title="GuptaR , DebbanehMG , LiaoW . Genetic epidemiology of psoriasis. Current Dermatology Reports2014;3(1):61-78. [PMID: 25580373]">Gupta 2014</a>). An allele may be described of either the part of a gene that was inherited from the father, or the other part of a gene that was inherited from the mother. HLA genes encode for certain proteins on the surface of cells that help control the immune system. Currently, it is estimated that genetic data explain only 30% of psoriasis (<a href="./references#CD011941-bbs2-0028" title="BarkerJ . Psoriasis heritability: 125 years and counting. British Journal of Dermatology2014;171(1):3-5. [PMID: 25066284]">Barker 2014</a>). <a href="./references#CD011941-bbs2-0077" title="Prieto-PérezR , CabaleiroT , DaudénE , OchoaD , RomanM , Abad-SantosF . Genetics of psoriasis and pharmacogenetics of biological drugs. Autoimmune Diseases2013;2013:613086. [PMID: 24069534]">Prieto‐Perez 2013</a> stated that "the many genes associated with psoriasis and the immune response include tumour necrosis factor alpha, interleukin 23, and interleukin 12." </p> <p><a href="./references#CD011941-bbs2-0077" title="Prieto-PérezR , CabaleiroT , DaudénE , OchoaD , RomanM , Abad-SantosF . Genetics of psoriasis and pharmacogenetics of biological drugs. Autoimmune Diseases2013;2013:613086. [PMID: 24069534]">Prieto‐Perez 2013</a> also referred to the development of new drugs (e.g. etanercept, adalimumab, infliximab, ustekinumab, secukinumab) that target cytokines (e.g. tumour necrosis factor alpha, p40 subunit of interleukin 23 and interleukin 12) and, as a result, suppress the unwanted dysregulated and more than usual immune response. <a href="./references#CD011941-bbs2-0027" title="BachelezH , ViguierM , TebbeyPW , LowesM , Suárez-FariñasM , CostanzoA , et al. The mechanistic basis for psoriasis immunopathogenesis: translating genotype to phenotype. Report of a workshop, Venice, 2012. British Journal of Dermatology2013;169(2):283-6. [PMID: 23941252]">Bachelez 2013</a> also addressed the involvement of the immune system in the pathogenesis of psoriasis and stated, for example, that interleukin 36 is strongly elevated in the keratinocytes of psoriatic tissue. </p> <p><a href="./references#CD011941-bbs2-0057" title="HuertaC , RiveroE , RodriguezLA . Incidence and risk factors for psoriasis in the general population. Archives of Dermatology2007;143(12):1559-65. [PMID: 18087008]">Huerta 2007</a> conducted a prospective cohort study with nested case‐control analysis, in which a group of people were followed over a period of time. A random sample of controls was matched to people who developed psoriasis by age, sex, and calendar year. Odds ratios were adjusted for age and other risk factors. The study found an association between previous skin disorders, infectious disorders, obesity, and smoking with the onset of psoriasis. The authors did not find an association with other potential risk factors, such as stress, diabetes (high blood sugar), hypertension (high blood pressure), hyperlipidaemia (high blood fat), cardiovascular disease, or rheumatoid arthritis. </p> </section> <section id="CD011941-sec-0020"> <h4 class="title">Comorbidity</h4> <p>Psoriasis may be associated with other diseases, such as arthritis, depression, inflammatory bowel disease, and cardiovascular diseases (<a href="./references#CD011941-bbs2-0072" title="Oliveira MdeF , Rocha BdeO , DuarteGV . Psoriasis: classical and emerging comorbidities. Anais Brasileiros de Dermatologia2015;90(1):9-20. [PMID: 25672294]">Oliveira 2015</a>). As inflammation is involved in some of the associated diseases, it can be speculated whether these diseases may be connected with psoriasis on the ground of common genetic and immune‐related factors. </p> </section> <section id="CD011941-sec-0021"> <h4 class="title">Health‐related quality of life</h4> <p>Psoriasis causes considerable psychological disability and has a major impact on a person's quality of life (<a href="./references#CD011941-bbs2-0079" title="RappSR , FeldmanSR , ExumML , Fleisher AB Jr, ReboussinDM . Psoriasis causes as much disability as other major medical diseases. Journal of the American Academy of Dermatology1999;41(3 Pt 1):401-7. [PMID: 10459113]">Rapp 1999</a>). Thus, perception of psychosocial disability and quality of life may be paramount when assessing the importance of the condition to an individual and the subsequent treatment of the disease (<a href="./references#CD011941-bbs2-0065" title="MenterA , GriffithsCE . Current and future management of psoriasis. Lancet2007;370(9583):272–84. [PMID: 17658398]">Menter 2007</a>). A patient‐reported index of disease severity is described above (DLQI). Wahl interviewed 22 hospitalised patients with psoriasis and found that bodily suffering was a core variable with regard to the patients' experience of living with psoriasis (<a href="./references#CD011941-bbs2-0095" title="WahlAK , GjengedalE , HanestadBR . The bodily suffering of living with severe psoriasis: in-depth interviews with 22 hospitalized patients with psoriasis. Qualitative Health Research2002;12(2):250-61. [PMID: 11837374]">Wahl 2002</a>). For people with psoriasis, itching is a measure of the effect the disease has on quality of life (<a href="./references#CD011941-bbs2-0099" title="ZhuB , Edson-HerediaE , GuoJ , Maeda-ChubachiT , ShenW , KimballAB . Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial. British Journal of Dermatology2014;171(5):1215-9. [PMID: 24749812]">Zhu 2014</a>). </p> </section> <section id="CD011941-sec-0022"> <h4 class="title">Cost</h4> <p>The financial burden on people with this disease and on healthcare providers is considerable and was about 35.2 billion dollars in the USA in 2013 (<a href="./references#CD011941-bbs2-0094" title="Vanderpuye-OrgleJ , ZhaoY , LuJ , ShresthaA , SextonA , SeaburyS , et al. Evaluating the economic burden of psoriasis in the United States. Journal of the American Academy of Dermatology2015;72(6):961-7. [PMID: 25882886]">Vanderpuye‐Orgle 2015</a>). It was estimated that incremental medical costs contributed 34.7%; reduced health‐related quality of life, 33.5%; and productivity losses, 31.8% (<a href="./references#CD011941-bbs2-0094" title="Vanderpuye-OrgleJ , ZhaoY , LuJ , ShresthaA , SextonA , SeaburyS , et al. Evaluating the economic burden of psoriasis in the United States. Journal of the American Academy of Dermatology2015;72(6):961-7. [PMID: 25882886]">Vanderpuye‐Orgle 2015</a>). </p> </section> </section> <section id="CD011941-sec-0023"> <h3 class="title" id="CD011941-sec-0023">Description of the intervention</h3> <p>Salt bath followed by artificial ultraviolet B light was developed to simulate exposure to salt and sunlight delivered during climatotherapy (relocation to a region with a climate more favourable to the outcome) at the Dead Sea (<a href="./references#CD011941-bbs2-0056" title="HuangA , SeitéS , AdarT . The use of balneotherapy in dermatology. Clinics in Dermatology2018;36(3):363-8. [PMID: 29908578]">Huang 2018</a>). For example, the whole body is soaked in salt water for 15 to 30 minutes, which may have various concentrations ranging from 1 g to 250 g sodium chloride dissolved in one litre water. The soaking is repeated several times a week for a maximum of 20 to 30 applications within a time period of eight weeks. After bathing, various doses of ultraviolet B (UVB) light are applied to the whole body (<a href="./references#CD011941-bbs2-0044" title="GambichlerT , KüsterW , KreuterA , AltmeyerP , HoffmannK . Balneophototherapy--combined treatment of psoriasis vulgaris and atopic dermatitis with salt water baths and artificial ultraviolet radiation. Journal of the European Academy of Dermatology and Venereology: JEADV2000;14(5):425-8. [PMID: 11305394]">Gambichler 2000a</a>). The combination of bathing in salt water with UVB bathing thereafter may be called balneophototherapy (<a href="./references#CD011941-bbs2-0050" title="HalverstamCP , LebwohlM . Nonstandard and off-label therapies for psoriasis. Clinics in Dermatology2008;26(5):546-53. [PMID: 18755374]">Halverstam 2008</a>). Patients with psoriasis could improve with balneophototherapy (<a href="./references#CD011941-bbs2-0051" title="HarariM , NovackL , BarthJ , DavidM , FrigerM , MosesSW . The percentage of patients achieving PASI 75 after 1 month and remission time after climatotherapy at the Dead Sea. International Journal of Dermatology2007;46(10):1087-91. [PMID: 17910722]">Harari 2007</a>). </p> <p>Treatments for people with chronic plaque psoriasis include a variety of alternatives such as: </p> <p> <ul id="CD011941-list-0001"> <li> <p>topical therapy including steroidal and non‐steroidal agents;</p> </li> <li> <p>systemic medications (<a href="./references#CD011941-bbs2-0083" title="SbidianE , ChaimaniA , Garcia-DovalI , DoG , HuaC , MazaudC , et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews2017, Issue 12. [DOI: 10.1002/14651858.CD011535.pub2]">Sbidian 2017</a>) including various biological drugs (<a href="./references#CD011941-bbs2-0071" title="NúñezM , HueteT , dela CuevaP , SacristánJA , HartzS , DillaT . A cost-per-number needed to treat analysis assessing the efficiency of biologic drugs in moderate to severe plaque psoriasis [Evaluación de la eficiencia de los tratamientos biológicos en la psoriasis moderada a grave en España: análisis de coste por número necesario a tratar (NNT)]. Actas Dermo-Sifiliográficas2019;110(7):546-53. [DOI: 10.1016/j.ad.2018.10.017] [PMID: 30851873]">Nunez 2019</a>), and additional investigational agents being studied (<a href="./references#CD011941-bbs2-0038" title="EllisAG , FlohrC , DruckerAM . Network meta-analyses of systemic treatments for psoriasis: a critical appraisal: Original Articles: Jabbar-Lopez ZK, Yiu ZZN, Ward V et al. Quantitative evaluation of biologic therapy options for psoriasis: a systematic review and network meta-analysis. J Invest Dermatol 2017; 137:1646-54. Sbidian E, Chaimani A, Garcia-Doval I et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev 2017; 12:CD011535. British Journal of Dermatology2019;180(2):282-8. [PMID: 30347448]">Ellis 2019</a>); </p> </li> <li> <p>phototherapy including UVB irradiation alone without bathing in salt water, and</p> </li> <li> <p>photochemotherapy including ultraviolet A (UVA) irradiation plus psoralen, a compound that aids the absorption of UVA irradiation by making the skin more susceptible to the effects of light rays. </p> </li> </ul> </p> <p>Ultraviolet radiation and its wavelength is defined by the International Commission on Illumination <a href="./references#CD011941-bbs2-0034" title="International Commission on Illumination (Commission Internationale de l'Eclairage). eILV online! searchable online database of the International Lighting Vocabulary (ILV) of the current version of the ILV (CIE S 017/E:2011). cie.co.at/index.php/Publications/eILV+online! (accessed 22 October 2016).">CIE 2011</a>: "radiation for which the wavelengths are shorter than those for visible radiation; the range between 100 nm and 400 nm is commonly subdivided into: UVA: 315 nm to 400 nm; UVB: 280 nm to 315 nm; and UVC: 100 nm to 280 nm". UVB may be subdivided by some authors in broad band (280 nm to 315 nm), narrow band (311), or selective band (300 nm to 315 nm). </p> <p>The choice of an appropriate therapy is associated with the grade of severity and may be used as comparators with salt baths. </p> <p> <ul id="CD011941-list-0002"> <li> <p>Topical therapy including steroidal and non‐steroidal agents may be mainly used for mild or localised disease (<a href="./references#CD011941-bbs2-0061" title="LebwohlM , TingPT , KooJY . Psoriasis treatment: traditional therapy. Annals of the Rheumatic Diseases2005;64(Suppl 2):ii83-6. [PMID: 15708945]">Lebwohl 2005</a>; <a href="./references#CD011941-bbs2-0065" title="MenterA , GriffithsCE . Current and future management of psoriasis. Lancet2007;370(9583):272–84. [PMID: 17658398]">Menter 2007</a>). </p> </li> <li> <p>Systemic medications are mainly used for severe or refractory disease (<a href="./references#CD011941-bbs2-0061" title="LebwohlM , TingPT , KooJY . Psoriasis treatment: traditional therapy. Annals of the Rheumatic Diseases2005;64(Suppl 2):ii83-6. [PMID: 15708945]">Lebwohl 2005</a>; <a href="./references#CD011941-bbs2-0065" title="MenterA , GriffithsCE . Current and future management of psoriasis. Lancet2007;370(9583):272–84. [PMID: 17658398]">Menter 2007</a>), which include various oral agents as well as injectable biological agents. </p> </li> <li> <p>Phototherapy including UVB irradiation alone without bathing in salt water may be used predominantly for moderate or more extensive disease (<a href="./references#CD011941-bbs2-0061" title="LebwohlM , TingPT , KooJY . Psoriasis treatment: traditional therapy. Annals of the Rheumatic Diseases2005;64(Suppl 2):ii83-6. [PMID: 15708945]">Lebwohl 2005</a>; <a href="./references#CD011941-bbs2-0065" title="MenterA , GriffithsCE . Current and future management of psoriasis. Lancet2007;370(9583):272–84. [PMID: 17658398]">Menter 2007</a>). </p> </li> <li> <p>Phototherapy and photochemotherapy may be also used for those not responding sufficiently to topical treatment (<a href="./references#CD011941-bbs2-0087" title="SinghRK , LeeKM , JoseMV , NakamuraM , UcmakD , FarahnikB , et al. The patient's guide to psoriasis treatment. Part 1: UVB phototherapy. Dermatology and Therapy2016;6(3):307-13. [PMID: 27474029]">Singh 2016</a>; <a href="./references#CD011941-bbs2-0093" title="vande KerkhofPC , VissersWH . Established treatments of psoriasis. Current Drug Targets - Inflammation &amp; Allergy2004;3(2):145-56. [PMID: 15180467]">van de Kerkhof 2004</a>); psoralen plus UVA (PUVA) light photochemotherapy may be used for moderate or severe disease (<a href="./references#CD011941-bbs2-0061" title="LebwohlM , TingPT , KooJY . Psoriasis treatment: traditional therapy. Annals of the Rheumatic Diseases2005;64(Suppl 2):ii83-6. [PMID: 15708945]">Lebwohl 2005</a>; <a href="./references#CD011941-bbs2-0065" title="MenterA , GriffithsCE . Current and future management of psoriasis. Lancet2007;370(9583):272–84. [PMID: 17658398]">Menter 2007</a>). For people with widespread chronic plaque psoriasis, phototherapy may be regarded as the first‐choice treatment because it may have fewer adverse events than systemic or biological agents (<a href="./references#CD011941-bbs2-0070" title="NguyenT , GattuS , PugashettiR , KooJ . Practice of phototherapy in the treatment of moderate-to-severe psoriasis. Current Problems in Dermatology2009;38:59-78. [PMID: 19710550]">Nguyen 2009</a>). Psoralen is a photosensitising compound that aids the absorption of UVA light and increases the skin's sensitivity to light, but subsequently may have carcinogenic properties (<a href="./references#CD011941-bbs2-0026" title="ArchierE , DevauxS , CastelaE , GalliniA , AubinF , Le MaîtreM , et al. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. Journal of the European Academy of Dermatology and Venereology: JEADV2012;26(Suppl 3):22-31. [PMID: 22512677]">Archier 2012</a>). It is administered either orally, in bath water, as a cream, or as a gel. Thus, PUVA is divided into oral PUVA, bath PUVA, and topical (cream) PUVA (<a href="./references#CD011941-bbs2-0012" title="ChenX , YangM , ChengY , LiuGJ , ZhangM . Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD009481.pub2]">Chen 2013</a>). <a href="./references#CD011941-bbs2-0068" title="MomtazK , FitzpatrickTB . The benefits and risks of long-term PUVA photochemotherapy. Dermatologic Clinics1998;16(2):227-34. [PMID: 9589196]">Momtaz 1998</a> reported that PUVA photochemotherapy has been used in psoriasis and 23 other skin disorders. The risk of development of squamous cell carcinomas may be high if the patients have received ionising radiation or inorganic arsenic, or if patients require continuous treatment for many years. Melanomas may also develop in a few patients. <a href="./references#CD011941-bbs2-0089" title="SternRS , LiebmanEJ , VäkeväL . Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. Journal of the National Cancer Institute1998;90(17):1278-84. [PMID: 9731734]">Stern 1998</a> warned that the use of PUVA should be weighed against the persistent, dose‐related increase in the risk of squamous cell cancer. </p> </li> </ul> </p> </section> <section id="CD011941-sec-0024"> <h3 class="title" id="CD011941-sec-0024">How the intervention might work</h3> <p>Salt bath, with or without phototherapy, is being widely used to treat moderate‐to‐severe psoriasis. The mechanism of action of UVB is not completely clear (<a href="./references#CD011941-bbs2-0097" title="WeatherheadSC , FarrPM , ReynoldsNJ . Spectral effects of UV on psoriasis. Photochemical &amp; Photobiological Sciences2013;12(1):47-53. [PMID: 23023652]">Weatherhead 2013</a>). UVB phototherapy for treating psoriasis may result in the induction of apoptosis (programmed cell death) of keratinocytes, which are the main cell types in the skin, as well as epidermal and dermal T lymphocytes (cells within the skin that are involved in inflammation) (<a href="./references#CD011941-bbs2-0096" title="WeatherheadSC , FarrPM , JamiesonD , HallinanJS , LloydJJ , WipatA , et al. Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation. Journal of Investigative Dermatology2011;131(9):1916-26. [PMID: 21614017]">Weatherhead 2011</a>; <a href="./references#CD011941-bbs2-0098" title="WongT , HsuL , LiaoW . Phototherapy in psoriasis: a review of mechanisms of action. Journal of Cutaneous Medicine &amp; Surgery2013;17(1):6-12. [PMID: 23364144]">Wong 2013</a>). The minimum amount of UVB that produces redness 24 hours after exposure is used as the starting dose for UVB light treatments; this 'minimal erythema dose' decreases after salt water bathing (<a href="./references#CD011941-bbs2-0043" title="GambichlerT , SchröplF . Changes of minimal erythema dose after water and salt water baths. Photodermatology, Photoimmunology &amp; Photomedicine1998;14(3-4):109-11. [PMID: 9779497]">Gambichler 1998</a>). </p> <p>There may be increased UV transmission to the skin after soaking in salt water (<a href="./references#CD011941-bbs2-0045" title="GambichlerT , DemetriouC , TerrasS , BecharaFG , SkryganM . The impact of salt water soaks on biophysical and molecular parameters in psoriatic epidermis equivalents. Dermatology2011;223(3):230-8. [PMID: 22056695]">Gambichler 2011</a>), which may lead to stronger inflammation (e.g. UV‐induced erythema) and also to increased apoptosis of keratinocytes and T lymphocytes, and thus improved clearance of psoriasis (<a href="./references#CD011941-bbs2-0045" title="GambichlerT , DemetriouC , TerrasS , BecharaFG , SkryganM . The impact of salt water soaks on biophysical and molecular parameters in psoriatic epidermis equivalents. Dermatology2011;223(3):230-8. [PMID: 22056695]">Gambichler 2011</a>; <a href="./references#CD011941-bbs2-0098" title="WongT , HsuL , LiaoW . Phototherapy in psoriasis: a review of mechanisms of action. Journal of Cutaneous Medicine &amp; Surgery2013;17(1):6-12. [PMID: 23364144]">Wong 2013</a>). The mechanism of action of low concentrations of sodium chloride in water used in indoor salt water baths followed by artificial UVB light is unknown. Speculative mechanisms have been proposed, for example, salt solutions might wash out unfavourable substances from the skin lesions, salt water bathing might increase skin sensitivity to UVB light and thereby increasing its action on the lesion, single salt components could act favourably on the cells of the skin lesions, the intervention might inhibit cell proliferation (<a href="./references#CD011941-bbs2-0084" title="SchemppCM , DitmarHC , HummlerD , Simon-HaarhausB , Schulte-MontigJ , SchopfE , et al. Magnesium ions inhibit the antigen-presenting function of human epidermal Langerhans cells in vivo and in vitro. Involvement of ATPase, HLA-DR, B7 molecules, and cytokines. Journal of Investigative Dermatology2000;115(4):680-6. [PMID: 10998143]">Schempp 2000</a>). </p> </section> <section id="CD011941-sec-0025"> <h3 class="title" id="CD011941-sec-0025">Why it is important to do this review</h3> <p>Studies suggest that indoor salt water baths with (<a href="./references#CD011941-bbs2-0031" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [PMID: 17714121]">Brockow 2007</a>), or without exposure to artificial UVB (<a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>), may benefit patients with psoriasis. However, the evidence underlying clinical efficacy, such as longer remission from disease and higher dermatology‐related quality of life, has not yet been clearly evaluated. It should be pointed out that the use of high concentrations of salt is cumbersome due to the large amounts of salt needed. Although indoor salt water baths are widely used in practice to treat chronic plaque psoriasis, no systematic review has been conducted to assess its effectiveness for reducing skin lesions and improving quality of life. Therefore, the aim of this review is to evaluate the efficacy and any severe adverse events of indoor salt water baths by focusing on patient‐centred outcomes. The methods planned for this review were published as a protocol: <i>Indoor salt water baths followed by artificial UVB light for chronic plaque psoriasis</i> (<a href="./references#CD011941-bbs2-0100" title="PeinemannF , HarariM , PeternelS , ChanT , GambichlerT . Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis. Cochrane Database of Systematic Reviews2015, Issue 11. [DOI: 10.1002/14651858.CD011941]">Peinemann 2015</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011941-sec-0026" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011941-sec-0026"></div> <p>To assess the effects of indoor salt water baths followed by exposure to artificial ultraviolet B (UVB) light for treating chronic plaque psoriasis in adults. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011941-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011941-sec-0027"></div> <section id="CD011941-sec-0028"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011941-sec-0029"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) that randomised people or limbs to either the test intervention or a control intervention. </p> <p>We did not find a reason to exclude right‐left comparative studies. Nevertheless, pretreatment of the skin of a body part investigated in a cross‐over design may influence the results as opposed to no pretreatment. To prevent the concerning additional bias, we excluded cross‐over designs. We suggested that simultaneous application of the intervention of interest on multiple body parts of each participant may distract the scoring of the Psoriasis Area and Severity Index (PASI) response and other subjective assessments. We are positive that right‐left comparative study should not include comparing different body parts. Different body parts may be affected differently and the assessment may introduce bias. We did not find a reason to exclude cluster‐randomised trials. Throughout the review, we used the term 'people or limbs' to accommodate people who were randomised, as well as randomised legs, arms, and elbows. </p> <p>We planned to include the following designs.</p> <p> <ul id="CD011941-list-0003"> <li> <p>Simple parallel group design according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>, section 9.3.1, quote: "participants are individually randomised to one of two intervention groups, and a single measurement for each outcome from each participant is collected and analyzed" (<a href="./references#CD011941-bbs2-0055" title="HigginsJP , AltmanDG , Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). </p> </li> <li> <p>Multiple observations for the same outcome, specifically repeated measurements. If the data were to be included in a meta‐analysis, we planned to select a single time point and to analyse only data at this time point for studies in which it was presented. </p> </li> <li> <p>Multiple observations for the same outcome, specifically, multiple body parts receive different interventions according to the Handbook section 9.3.8, quote: "These trials have similarities to cross‐over trials: whereas in cross‐over trials individuals receive multiple treatments at different times, in these trials they receive multiple treatments at different sites." (<a href="./references#CD011941-bbs2-0055" title="HigginsJP , AltmanDG , Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). In the present review, we considered paired comparisons within participants, such as comparisons of right versus left arm, leg, elbow, or knee. We planned to separately analyse the within‐participant data and the between‐participant data. </p> </li> <li> <p>Cluster‐randomised trials according to the Cochrane Handbook section 9.3.2, quote: "groups of participants, such as schools or families are randomized to different interventions. [...] Participants within any cluster often tend to respond in a similar manner, and thus their data can no longer be assumed to be independent of one another" (<a href="./references#CD011941-bbs2-0055" title="HigginsJP , AltmanDG , Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). </p> </li> </ul> </p> <p>We did not include the following study designs.</p> <p> <ul id="CD011941-list-0004"> <li> <p>Cross‐over design according to the Handbook section 9.3.3, quote: "all participants receive all interventions in sequence: they are randomized to an ordering of interventions, and participants act as their own control.". We expected a high risk of carryover according to the Handbook section 16.4.2, quote: "Carryover is the situation in which the effects of an intervention given in one period persist into a subsequent period, thus interfering with the effects of different subsequent intervention" (<a href="./references#CD011941-bbs2-0055" title="HigginsJP , AltmanDG , Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). </p> </li> <li> <p>Multiple observations for the same outcome, specifically, multiple body parts receive the same intervention according to the Handbook section 9.3.7, quote: "people are randomized, but multiple parts (or sites) of the body receive the same intervention, a separate outcome judgement being made for each body part, and the number of body parts is used as the denominator in the analysis. [...] This is similar to the situation in cluster‐randomized trials, except that participants are the 'clusters" (<a href="./references#CD011941-bbs2-0055" title="HigginsJP , AltmanDG , Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). </p> </li> <li> <p>Comparison of different body parts within participants, such as comparing arm versus leg. </p> </li> </ul> </p> </section> <section id="CD011941-sec-0030"> <h4 class="title">Types of participants</h4> <p>Adults (i.e. 18 years of age or older) of any ethnic background or gender who have been diagnosed with chronic plaque type psoriasis by a dermatologist. We excluded people with pustular psoriasis, guttate psoriasis, or inverse psoriasis. </p> </section> <section id="CD011941-sec-0031"> <h4 class="title">Types of interventions</h4> <p>The aim of this review was to assess the efficacy of salt bath added to ultraviolet B (UVB) light. We did not seek to assess efficacy of salt bath only. </p> <section id="CD011941-sec-0032"> <h5 class="title">Comparison 1: salt bath + UVB versus other treatment without UVB</h5> <section id="CD011941-sec-0033"> <h6 class="title">Test intervention</h6> <p>Exposure to indoor salt water bath followed by artificial UVB light for chronic plaque psoriasis. We included studies where bathing in salt water was performed indoors during or prior to exposure to UVB. We excluded studies where bathing in salt water was performed outdoors and for leisure purposes, such as bathing in geothermal sea water, bathing in a thermal lagoon, or bathing in a salty lake. </p> </section> <section id="CD011941-sec-0034"> <h6 class="title">Control intervention</h6> <p>Exposure to psoralen bath, psoralen bath + artificial ultraviolet A (UVA) light, topical treatment, systemic treatment, or placebo. </p> </section> </section> <section id="CD011941-sec-0035"> <h5 class="title">Comparison 2: salt bath+ UVB versus other treatment + UVB or UVB only</h5> <section id="CD011941-sec-0036"> <h6 class="title">Test intervention</h6> <p>Exposure to indoor salt water bath followed by artificial UVB for chronic plaque psoriasis. We included studies where bathing in salt water is performed indoors during or prior to exposure to UVB. We excluded studies where bathing in salt water is performed outdoors and for leisure purposes, such as bathing in geothermal sea water, bathing in a thermal lagoon, or bathing in a salty lake. </p> </section> <section id="CD011941-sec-0037"> <h6 class="title">Control intervention</h6> <p>Exposure to bath containing other compositions or concentrations + UVB or UVB only.</p> </section> </section> </section> <section id="CD011941-sec-0038"> <h4 class="title">Types of outcome measures</h4> <p>We did not use the outcomes listed here as criteria for including studies; they are the outcomes of interest within studies identified for inclusion. </p> <section id="CD011941-sec-0039"> <h5 class="title">Primary outcomes</h5> <p>Between‐participant data as well as within‐participant data:</p> <p> <ol id="CD011941-list-0005"> <li> <p>physician‐assessed outcome: psoriasis area and severity index (PASI)‐75;</p> </li> <li> <p>physician‐assessed outcome: treatment‐related adverse events requiring withdrawal.</p> </li> </ol> </p> </section> <section id="CD011941-sec-0040"> <h5 class="title">Secondary outcomes</h5> <p>Between‐participant as well as within‐participant data:</p> <p> <ol id="CD011941-list-0006"> <li> <p>participant‐reported outcome: dermatology life quality index (DLQI);</p> </li> <li> <p>participant‐reported outcome: pruritus severity using a visual analogue scale (VAS) from 0 ('no itching') to 100 ('severe itching'); </p> </li> <li> <p>physician‐reported outcome: time to relapse;</p> </li> <li> <p>physician‐assessed outcome: secondary malignancies.</p> </li> </ol> </p> <p>We did not consider using the Physician Global Assessment (PGA), because we favoured PASI, which is reportedly validated and preferred for use in clinical trials (<a href="./references#CD011941-bbs2-0081" title="RobinsonA , KardosM , KimballAB . Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology2012;66(3):369-75. [PMID: 22041254]">Robinson 2012</a>). </p> </section> </section> </section> <section id="CD011941-sec-0041"> <h3 class="title">Search methods for identification of studies</h3> <p>We aimed to identify all relevant RCTs regardless of language or publication status (published, unpublished, in press, or in progress). </p> <section id="CD011941-sec-0042"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Skin Information Specialist searched the following databases up to 4 June 2019: </p> <p> <ul id="CD011941-list-0007"> <li> <p>the Cochrane Skin Group Specialised Register using the search strategy in <a href="./appendices#CD011941-sec-0147">Appendix 1</a>; </p> </li> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL) 2019, Issue 6 in the Cochrane Library using the strategy in <a href="./appendices#CD011941-sec-0148">Appendix 2</a>; </p> </li> <li> <p>MEDLINE via Ovid (from 1946) using the strategy in <a href="./appendices#CD011941-sec-0149">Appendix 3</a>; </p> </li> <li> <p>Embase via Ovid (from 1974) using the strategy in <a href="./appendices#CD011941-sec-0150">Appendix 4</a>; and </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information database, from 1982) using the strategy in <a href="./appendices#CD011941-sec-0151">Appendix 5</a>. </p> </li> </ul> </p> <section id="CD011941-sec-0043"> <h5 class="title">Online trials registers</h5> <p>We (FP, SP) searched the following online trials registers up to 6 June 2019 using the term 'psoriasis' in the field 'condition' and 'phototherapy' in the field 'intervention': </p> <p> <ul id="CD011941-list-0008"> <li> <p>the ISRCTN registry (<a href="http://www.isrctn.com" target="_blank">www.isrctn.com</a>) (called 'The metaRegister of Controlled Trials' in the protocol); </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>) (called 'The US National Institutes of Health Ongoing Trials Register' in the protocol); </p> </li> <li> <p>the Australian New Zealand Clinical Trials Registry (<a href="http://www.anzctr.org.au" target="_blank">www.anzctr.org.au</a>); </p> </li> <li> <p>the World Health Organization International Clinical Trials Registry Platform (ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>); and </p> </li> <li> <p>the EU Clinical Trials Register (<a href="https://www.clinicaltrialsregister.eu/" target="_blank">www.clinicaltrialsregister.eu</a>). </p> </li> </ul> </p> </section> </section> <section id="CD011941-sec-0044"> <h4 class="title">Searching other resources</h4> <section id="CD011941-sec-0045"> <h5 class="title">References from bibliographies</h5> <p>We checked the bibliographies of included studies, relevant articles, and review articles for further references to relevant trials. </p> </section> <section id="CD011941-sec-0046"> <h5 class="title">Adverse effects</h5> <p>We did not perform a separate search for adverse effects of the target intervention. However, we examined data on adverse effects from the included studies that we identified. </p> </section> </section> </section> <section id="CD011941-sec-0047"> <h3 class="title" id="CD011941-sec-0047">Data collection and analysis</h3> <p>Some parts of the methods section of this Cochrane Review used text that was originally published in other Cochrane publications co‐authored by FP and protocol contributor Doreen Tushabe (predominantly <a href="./references#CD011941-bbs2-0075" title="PeinemannF , BartelC , GrouvenU , BertholdF . Retinoic acid post consolidation therapy for high-risk neuroblastoma. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD010685]">Peinemann 2013a</a> and <a href="./references#CD011941-bbs2-0076" title="PeinemannF , TushabeDA , BertholdF . Rapid COJEC versus standard induction therapies for high-risk neuroblastoma. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD010774]">Peinemann 2013b</a>), as well as using text that was originally published in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011941-bbs2-0055" title="HigginsJP , AltmanDG , Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). </p> <section id="CD011941-sec-0048"> <h4 class="title">Selection of studies</h4> <p>While preparing this systematic review, we endorsed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) statement, adhered to its principles and conformed to its checklist (<a href="./references#CD011941-bbs2-0067" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Medicine2009;6:e1000097. [PMID: 19621072]">Moher 2009</a>). We downloaded all titles and abstracts retrieved by electronic searching to an Excel spreadsheet (<a href="./references#CD011941-bbs2-0066" title="Microsoft Excel. Redmond: Microsoft Corporation, 2011.">Microsoft Corp 2011</a>), and removed any duplicates. Two review authors (FP, SP) independently examined any remaining references. We included a study selection flow chart in the review (<a href="#CD011941-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD011941-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011941-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>We excluded those studies that clearly did not meet the inclusion criteria and obtained copies of the full text of potentially relevant references. Two review authors (FP, SP) independently assessed the eligibility of retrieved papers. We resolved any disagreements by discussion between the two review authors; no third party arbitration was necessary. We documented reasons for exclusion in the <a href="./references#CD011941-sec-0163" title="">Characteristics of excluded studies</a> tables. If we identified multiple reports of one study we used the most‐up‐to‐date full‐text results. We checked the multiple reports for possible duplicate data, addressed the issue and did not include duplicate data in the analysis. </p> </section> <section id="CD011941-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>For each included study, two review authors (FP, SP) extracted study characteristics and outcomes independently onto a data extraction form. The data included: information on study design, participant characteristics (such as inclusion criteria, age, disease severity, comorbidity, previous treatment, number enrolled in each arm), interventions (such as type of irradiation, type of bath, dose applied, duration of therapy, control treatment), risk of bias, follow‐up duration, outcome measures, and deviations from the study protocol. We pilot tested <i>The Cochrane Editorial Resources Committee's data collection form for intervention reviews</i> (for RCTs only) available from the Cochrane Skin Group website: <a href="http://www.skin.cochrane.org/resources" target="_blank">www.skin.cochrane.org/resources</a>, then used this for data extraction. We resolved differences between review authors by discussion. </p> </section> <section id="CD011941-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (FP, SP) independently appraised the risk of bias in the included studies. We resolved differences between review authors by discussion. We used the items listed within Cochrane's tool for assessing risk of bias (<a href="./references#CD011941-bbs2-0055" title="HigginsJP , AltmanDG , Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>): </p> <p> <ul id="CD011941-list-0009"> <li> <p>random sequence generation (selection bias);</p> </li> <li> <p>allocation concealment (selection bias);</p> </li> <li> <p>blinding of participants and personnel (performance bias);</p> </li> <li> <p>blinding of outcome assessment (detection bias);</p> </li> <li> <p>incomplete outcome data such as missing data (attrition bias);</p> </li> <li> <p>selective reporting such as not reporting pre‐specified outcomes (reporting bias); and </p> </li> <li> <p>other sources of bias such as bias related to the specific study design (other bias).</p> </li> </ul> </p> <p>In general, a judgement of "low risk" of bias was given if plausible bias is unlikely to seriously alter the results, for example, if the participants and investigators enrolling those participants could not foresee the assignment. A judgement of "high risk" of bias was given if plausible bias seriously weakens confidence in the results, for example, if the participants or investigators enrolling those participants could possibly foresee the assignments. A judgement of "unclear" risk of bias was given if plausible bias raises some doubt about the results, for example, the method of concealment is not described or not described in sufficient detail to allow a definite judgement. </p> <p>To draw conclusions about the overall risk of bias for an outcome, it was necessary to summarise the results of the 'Risk of bias' assessments performed for each individual study. We assessed the risk of bias at study level, not by outcome. We aligned the summary assessment to the Cochrane 'Possible approach for summary assessments of the risk of bias for each important outcome (across domains) within and across studies', as shown in Table 8.7a in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011941-bbs2-0055" title="HigginsJP , AltmanDG , Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). We assessed whether the risk of bias for a single outcome was low, unclear, or high, then we interpreted whether the plausible bias was unlikely to seriously alter the results, raises some doubts about the results, or seriously weakened the confidence in the results. We assessed within a study whether there was a low risk of bias for all key domains, an unclear risk of bias for one or more domains, or a high risk of bias for one or more key domains. We assessed across studies whether most information was from studies at low risk of bias or at high or unclear risk of bias, and we assessed across studies whether the proportion of information from studies at high risk of bias was sufficient to affect the interpretation of results. </p> </section> <section id="CD011941-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>For time‐to‐event data such as survival, we planned to extract the hazard ratio (HR) and its standard error or confidence interval (CI) from trial reports; if these were not reported, we planned to estimate the logHR and its standard error using the methods of <a href="./references#CD011941-bbs2-0074" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine1998;17(24):2815-34. [PMID: 9921604]">Parmar 1998</a> and using the tool provided by <a href="./references#CD011941-bbs2-0091" title="TierneyJF , StewartLA , GhersiD , BurdettS , SydesMR . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials2007;8:16. [PMID: 17555582]">Tierney 2007</a>. </p> <p>For dichotomous data, such as PASI‐75 and treatment‐related adverse events requiring withdrawal, we estimated the proportion of events among the assessed participants. We pooled the data and estimated a risk ratio (RR) and a P value for overall effect by using the Mantel‐Haenszel statistic and a fixed‐effect model. If the P value was not reported by the study, then we estimated the P value by using the web‐based Easy Fisher Exact Test Calculator (<a href="./references#CD011941-bbs2-0088" title="StangroomJ . Easy Fisher Exact Test Calculator for 2 x 2 Contingency Table. www.socscistatistics.com/tests/Default.aspx (accessed 29 June 2018).">Social Science Statistics 2018</a>). In case of rare events, we planned to use Peto odds ratios instead, but this was not applied. </p> <p>For continuous outcomes (e.g. PASI), we planned to extract the final value or change from baseline and corresponding standard deviation (SD) of the outcome of interest and the number of people or limbs assessed at endpoint in each treatment arm at the end of follow‐up. This was in order to estimate the mean difference (MD) or standardised mean difference (SMD) between treatment arms. We planned to analyse and present continuous data using the MD if all results were measured on the same scale (e.g. PASI). If this was not the case (e.g. fear, or quality of life), we planned to use the SMD. Eligible continuous outcomes were not reported. </p> <p>We planned to extract the proportion of participants who reached the 50% reduction of the respective psoriatic lesion score compared to the baseline value at a fixed time point to allow pooling of data. If this was not possible, we planned to extract the time necessary to reach 50% reduction compared to baseline value. To calculate a mean difference, the number of people at risk and the probability of an event at a given time is required. Where studies did not provide that information, we chose to describe the individual results and not to pool the data. If data were given in a chart, we deduced the numbers from the chart. </p> <p>Where possible, all data that we extracted were those relevant to an intention‐to‐treat (ITT) analysis in which all data were analysed in groups to which they were assigned. We stated if this was not possible. We noted the time points at which outcomes were collected and reported. We reported the 95% CIs for all analyses. </p> </section> <section id="CD011941-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>We included between‐participant data as well as within‐participant data. In general, within‐participant studies apply the intervention to a body part such as a limb and the comparator to a different body part such as the opposite limb (e.g. right arm versus left arm). Those data are distinct. Consequently, we separately analysed and reported information on between‐participant data and within‐participant data. PASI‐75 is the primary efficacy outcome for both data types. </p> <p>If studies reported multiple intervention groups, we designated the intervention group and each different comparator group. </p> </section> <section id="CD011941-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>We conformed to Cochrane's principal options for dealing with missing data (<a href="./references#CD011941-bbs2-0055" title="HigginsJP , AltmanDG , Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). If data were missing, or only imputed data were reported, we planned to contact trial authors to request data on the outcomes of the people or limbs of the study. When relevant data regarding study selection, data extraction, and 'Risk of bias' assessment were missing, we planned to contact study authors to retrieve the missing data. If data remained missing after contact with authors, we analysed only the available data and addressed the potential impact on the findings in the <a href="#CD011941-sec-0135">Discussion</a>. </p> </section> <section id="CD011941-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to assess heterogeneity (composed of dissimilar parts) between studies by visual inspection of forest plots; by estimation of the percentage heterogeneity between trials that could not be ascribed to sampling variation (I² statistic) (<a href="./references#CD011941-bbs2-0054" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60. [PMID: 12958120]">Higgins 2003</a>); and if possible, by subgroup analyses. If there was evidence of substantial heterogeneity, we planned to investigate and report the possible reasons for this. An I² statistic greater than 50% was considered to indicate substantial heterogeneity, demonstrating a considerable variation in results. In this case, we planned to present the graphical display of a forest plot, but we did not plan to report an average value for the intervention effect. </p> </section> <section id="CD011941-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to assess study protocols to see if the planned outcomes have been reported, but did not identify any. We planned to assess reporting bias, such as publication bias, by constructing a funnel plot if there were a sufficient number of included studies for a particular outcome (that is, at least 10 studies included in a meta‐analysis). </p> </section> <section id="CD011941-sec-0056"> <h4 class="title">Data synthesis</h4> <p>We analysed the data using the Review Manager 5.3 software (<a href="./references#CD011941-bbs2-0080" title="Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>); one review author entered the data (FP) and another review author checked it (SP). If sufficient clinically similar studies were available, we deemed it feasible to pool data. We planned to consider clinical homogeneity and statistical heterogeneity before pooling the data. If the I² statistic value was greater than 50%, we did not combine studies in order to report an average value for the intervention effect. We planned to use random‐effects models with inverse variance weighting for all analyses (<a href="./references#CD011941-bbs2-0037" title="DerSimonianR , LairdN . Meta-analysis in clinical trials. Controlled Clinical Trials1986;7(3):177-88. [PMID: 3802833]">DerSimonian 1986</a>). </p> <p>Concerning the dichotomous events of PASI‐75 and treatment‐related adverse events requiring withdrawal, we pooled the data and estimated a risk ratio and a P value for overall effect by using the Mantel‐Haenszel statistic and a fixed‐effect model. </p> <p>Where possible, all data that we extracted were those relevant to an intention‐to‐treat (ITT) analysis in which all data were analysed in groups to which they were assigned. We stated if this was possible. We noted the time points at which outcomes were collected and reported. We reported the 95% confidence intervals (CIs) for all analyses. </p> <p>We planned to use ordinal data from people who answered the Dermatology Life Quality Index (DLQI) questionnaire (<a href="#CD011941-tbl-0003">Table 2</a>) (<a href="./references#CD011941-bbs2-0064" title="MelilliL , ShikiarR , ThompsonC . Minimum clinically important difference in Dermatology Life Quality Index in moderate to severe plaque psoriasis patients treated with adalimumab (P2894). Journal of the American Academy of Dermatology2006;54(3 Suppl):AB 221. [www.jaad.org/article/S0190-9622(05)04271-4/pdf]">Melilli 2006</a>) or the visual analogue scale (VAS) on pruritus (itching), as well as from people who achieved a remission and people who experienced secondary malignancy. However, these data were not reported. </p> <p>In the protocol, we addressed a problem that might arise if we included only a single study in an analysis of dichotomous data. In this instance, the confidence intervals around risk ratios calculated in <a href="./references#CD011941-bbs2-0080" title="Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a> are unreliable. Where results were estimated for individual studies with low numbers of outcomes (less than 10 in total), or where the total sample size was less than 30 people, or limbs and a risk ratio was used, we planned to report the proportion of outcomes in each treatment group together with a P value from a Fisher's exact test. But this problem did not arise. </p> <p>The analysis should be in intention‐to‐treat and all missing data were considered as failure. </p> <p>Results on outcomes that were not predefined were also reported in <a href="#CD011941-sec-0086">Effects of interventions</a> as additional information, though, the results were not relevant for the conclusion of the present review. </p> <section id="CD011941-sec-0057"> <h5 class="title">'Summary of findings' tables and GRADE assessments</h5> <p>We prepared one 'Summary of findings' table using the GRADE profiler software (<a href="./references#CD011941-bbs2-0047" title="GRADEpro GDT. Version (accessed January 2017). Hamilton (ON): Grade Working Group, McMaster University, 2014.">GRADEpro GDT 2014</a>) concerning the comparison of between‐participant data: salt bath + UVB compared with other treatment + UVB. We listed the predefined two primary outcomes: PASI‐75 and treatment‐related adverse events requiring withdrawal. For each outcome, two review authors (FP, SP) independently assessed the certainty of the evidence by using the five GRADE considerations, that is, study limitations, inconsistency, indirectness, imprecision, and publication bias as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011941-bbs2-0086" title="SchünemannHJ , OxmanAD , VistGE , HigginsJP , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Schünemann 2011</a>). Due to lack of data, we did not prepare other 'Summary of findings' tables, which might be possible for comparison type one regarding between‐participant data and for both comparison types regarding within‐participant data. </p> </section> </section> <section id="CD011941-sec-0058"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did not undertake any subgroup analyses.</p> </section> <section id="CD011941-sec-0059"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct a sensitivity analysis removing studies at high or uncertain risk of bias. However, we did not undertake any sensitivity analyses due to the limited number of studies included in this review. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011941-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011941-sec-0060"></div> <section id="CD011941-sec-0061"> <h3 class="title">Description of studies</h3> <section id="CD011941-sec-0062"> <h4 class="title">Results of the search</h4> <p>The <a href="#CD011941-sec-0042">Electronic searches</a> of databases and online trials registers retrieved 281 records (142 from databases and 139 from online trials registries) once duplicates were removed (<a href="#CD011941-fig-0001">Figure 1</a>). We screened the title and abstract of 281 records and excluded 254 records. We screened the full texts of the remaining 27 records and included 11 records and did not include 16 records. The exclusion reasons for 15 records (<a href="./references#CD011941-bbs1-0002" title="">Excluded studies</a>) are shown in the <a href="./references#CD011941-sec-0163" title="">Characteristics of excluded studies</a>. One record is listed in <a href="./references#CD011941-bbs1-0003" title="">Studies awaiting classification</a>, and described in <a href="./references#CD011941-sec-0164" title="">Characteristics of studies awaiting classification</a>. The latter record (<a href="./references#CD011941-bbs2-0024" title="NCT02713711. Effectiveness of artificial balneotherapy, phototherapy and artificial balneophototherapy in the treatment of psoriasis. clinicaltrials.gov/ct2/show/NCT02713711 Date first received: 10 March 2016. ">NCT02713711</a>) could be an eligible study for inclusion in a future update. The results and full description of the methods of the study were not available. We included eight studies (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>) associated with 11 records. For a full description of our screening process, see <a href="#CD011941-fig-0001">Figure 1</a>. </p> </section> <section id="CD011941-sec-0063"> <h4 class="title">Included studies</h4> <p>Of the 27 potentially relevant records, we included 11 records (<a href="./references#CD011941-bbs1-0001" title="">Included studies</a>), which are associated with eight different studies (<a href="#CD011941-fig-0001">Figure 1</a>). The characteristics of the eight included studies are described in the <a href="./references#CD011941-sec-0162" title="">Characteristics of included studies</a> tables. </p> <section id="CD011941-sec-0064"> <h5 class="title">Design and sample sizes</h5> <p>We included eight randomised controlled trials (RCTs) (2105 participants; 1976 analysed) in this review. Six studies were parallel RCTs (2035 participants; 1908 analysed) that randomised patients to an intervention or comparator group (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> randomised participants to an intervention group (24 analysed), or two different comparator groups (22 and 21 analysed). <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> randomised participants to an intervention group (299 analysed), or three different comparator groups (270, 285, and 305 analysed). Two studies (70 participants; 68 analysed) were within‐participants studies (140 limbs; 136 analysed) (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>). <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a> randomised arms or legs to an intervention or comparator group (120 limbs; 116 analysed), and <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a> randomised elbows to an intervention or comparator group (20 limbs; 20 analysed). The majority of studies did not report the recruitment periods. The earliest reported recruitment happened in the year 2001. </p> <p>Assessment at the end of treatment was reported by seven studies: up to eight weeks (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>), six weeks (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>), six weeks (<a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>), eight weeks (<a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>), seven weeks (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>), three weeks (<a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>), and eight weeks (<a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>) after start of treatment. In one study (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>), we did not identify a clear reporting of treatment duration. Assessment at the end of follow‐up was reported by six studies: up to eight months (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>), six months (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>), six months (<a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>), 12 months (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>), six months (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>), 12 months (<a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>) after end of treatment. In two studies (<a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>), we did not identify a clear reporting of follow‐up duration. The duration of trials in total (start of treatment to end of follow‐up) was roughly: up to four months (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>), up to eight months (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>), up to eight months (<a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>), at least 12 months (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>), at least two months (<a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>), up to eight months (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>), up to 13 months (<a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>), and at least two months (<a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). </p> </section> <section id="CD011941-sec-0065"> <h5 class="title">Setting</h5> <p>Five of the eight included studies were set in Germany (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>), and a single study was set in the Netherlands (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>), the UK (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>), and France (<a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>), respectively. Four studies were conducted in a single centre (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>), and the remaining four studies (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>) were conducted in more than one centre. Five studies reported the recruitment of outpatients (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>), and the other three studies did not report any information on recruitment (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>). One single‐centre study was conducted in the Psoriasis Day Care Centre at Ede, the Netherlands. Another single‐centre study was conducted in a spa centre at Salies‐de‐Bearn, France. Two other single‐centre studies were conducted; one in Germany and one in the UK. Four multi‐centre studies were conducted in spa centres or outpatient clinics in Germany. Three of eight studies were sponsored by commercial spa or salt companies (German Spas Association (Deutscher Heilbäderverband); Mavena Healthcare AG, Switzerland, the commercial spa facility La Compagnie Fermiere de Salies de Bearn), one by health insurance companies ("primary" health insurance companies in Bavaria, Germany), one by an association of dermatologists (Berufsverband der Deutschen Dermatologen, Germany), and three did not report on funding. </p> </section> <section id="CD011941-sec-0066"> <h5 class="title">Participants</h5> <p>The study participants were diagnosed with psoriasis by a dermatologist. Six studies reported a mean age range from 41 to 49 years of age in the intervention group, and from 45 to 50 years of age in the control group (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). One study reported a mean age of 36 years in the intervention group and 46 years of age in the comparator group (<a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>). One study did not report information on age (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>). Four studies reported male gender from 56% to 74% in the intervention group and from 60% to 62% in the control group (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). Two studies reported male gender in 40% and 57% for all people or limbs, respectively (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>). Two studies did not report information on gender (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>). </p> <p>All eight included studies reported on assessing the skin type by using the Fitzpatrick phototyping scale (<a href="./references#CD011941-bbs2-0040" title="FitzpatrickTB . The validity and practicality of sun-reactive skin types I through VI. Archives of Dermatology1988;124(6):869-71.">Fitzpatrick 1988</a>), which results in six categories. Most participants were categorised type III, in some studies, a considerable fraction of participants were also categorised II and IV. According to the Australian Radiation Protection and Nuclear Safety Agency (<a href="https://www.arpansa.gov.au/sites/default/files/legacy/pubs/RadiationProtection/FitzpatrickSkinType.pdf" target="_blank">ARPANSA</a>): "The Fitzpatrick skin phototype is a commonly used system to describe a person's skin type in terms of response to ultraviolet radiation (UVR) exposure." The various types correspond to pale white skin (I), white skin (II), light brown skin (III), moderate brown skin (IV), dark brown skin (V), and deeply pigmented dark brown to black skin (VI). </p> <p>As a measure of severity of disease, the PASI score ranging from 0 to 72 points was assessed at the beginning of the study in five studies (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). In the test arm versus control arms, the median PASI score was 17 versus 16 (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>), 17 versus 18 (<a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>), 15.1 versus 15.3 (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>), 15.0 versus 15.7 (<a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>), and 16 versus 16 versus 17 versus 17 (<a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). Concerning baseline PASI score, there was no imbalance between treatment arms. Three studies (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>) did not report the PASI score. </p> <p>Four of the studies reporting between‐participant data (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>) stated the proportion of participants who had any experience of former phototherapy, which was balanced across the treatment groups. Three studies (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>) reported that between 80% and 90% of included participants had previous phototherapy, while one study (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>) reported a smaller proportion between 10% and 15%. One of the studies reporting within‐participant data (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>) reported a proportion of 75%. </p> <p>Four of the studies reporting between‐participant data (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>) stated the proportion of participants who had previous systematic therapy due to psoriasis, which was balanced across the treatment groups. Three studies (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>) reported that between 20% and 40% of included participants had previous systematic therapy, while one study (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>) reported a smaller proportion between 1% and 3%. One of the studies reporting within‐participant data (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>) reported a proportion of 12%. </p> <p>Three of the studies reporting between‐participant data (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>) stated the proportion of participants who had previous inpatient care due to psoriasis, which was balanced across the treatment groups. These studies reported that between 40% and 60% of included participants had previous inpatient care. <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> reported that about 55% of participants had previous topical treatment due to psoriasis. </p> <p>Three studies reported on the duration of disease. Two of the studies reporting between‐participant data (<a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>) reported a mean or median duration of 15 to 20 years. One of the studies reporting within‐participant data (<a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>) reported a mean duration of 2.5 years. </p> </section> <section id="CD011941-sec-0067"> <h5 class="title">Interventions and comparisons</h5> <p>To make various salt concentrations comparable, we converted the information on salt solutions into the unit g/L (<a href="#CD011941-tbl-0004">Table 3</a>). </p> <div class="table" id="CD011941-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Salt concentrations</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparator</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7 g/L NaCl dissolved in tap water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.7 mg/L psoralen dissolved in tap water</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>250 to 270 g/L NaCl present in natural spring water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no bath</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45 to 120 g/L NaCl present in natural spring water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no bath</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150 g/L Dead Sea salt dissolved in tap water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no bath</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>240 g/L NaCl dissolved in tap water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2 g/L present in tap water</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 g/L Dead Sea salt dissolved in tap water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no bath</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>250 g/L NaCl present in natural sping water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no bath</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>250 g/L NaCL dissolved in tap water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5 mg/L psoralen dissolved in tap water</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>NaCl: sodium chloride</p> </div> </div> <section id="CD011941-sec-0068"> <h6 class="title">Comparison 1: salt bath + UVB versus other treatment without UVB</h6> <p>We identified one comparison in one of the studies reporting between‐participant data (<a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> randomised 310 participants to the intervention group salt water + UVB and randomised 321 participants to the comparator group psoralen bath + UVA. </p> <p> <ul id="CD011941-list-0010"> <li> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>: salt bath + UVB versus psoralen bath + UVA </p> </li> </ul> </p> <p>We did not identify comparisons in the studies reporting within‐participants data</p> </section> <section id="CD011941-sec-0069"> <h6 class="title">Comparison 2: salt bath + UVB versus other treatment + UVB or UVB only</h6> <p>We identified seven comparisons in the six studies reporting between‐participant data (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). UVB was applied in addition to another treatment, such as psoralen bath or tap water bath in two comparator groups. UVB only was applied in five comparator groups. <a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a> randomised 20 participants to the intervention group salt water + UVB and 20 participants to the comparator group psoralen bath + UVB. <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> randomised 310 participants to the intervention group salt bath + UVB, randomised 301 participants to the comparator group UVB only, and randomised 301 participants to tap water + UVB. The other studies (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>) randomised participants to the intervention group salt bath + UVB, and to the comparator group UVB only. </p> <p> <ul id="CD011941-list-0011"> <li> <p><a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>: salt bath + UVB versus psoralen bath + UVB </p> </li> <li> <p><a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>: salt bath <b>+</b> UVB versus UVB only </p> </li> <li> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>: salt bath <b>+</b> UVB versus UVB only </p> </li> <li> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>: salt bath <b>+</b> UVB versus UVB only </p> </li> <li> <p><a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>: salt bath <b>+</b> UVB versus UVB only </p> </li> <li> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>: salt bath <b>+</b> UVB versus UVB only </p> </li> <li> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>: salt bath <b>+</b> UVB versus tap water + UVB </p> </li> </ul> </p> <p>We identified two comparisons in the two studies reporting within‐participants data (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>). Both studies randomised body parts to salt water + UVB versus UVB only. </p> <p> <ul id="CD011941-list-0012"> <li> <p><a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>: salt bath + UVB versus UVB only </p> </li> <li> <p><a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>: salt bath + UVB versus UVB only </p> </li> </ul> </p> <section id="CD011941-sec-0070"> <p><b>Salt bath</b></p> <p>People, legs, arms, or elbows were soaked for 15 to 30 minutes in salt water with a sodium chloride salt concentration ranging from 0.8 g/L to 250 g/L. The sources were natural springs in three studies (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>), dissolved sodium chloride in tap water in three studies (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>), and dissolved commercial Dead Sea salt in tap water in two studies (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>). In general, salt bath + UVB was applied once a day, three to five days a week, for up to eight weeks, and reaching a maximum number of 15 to 35 applications. </p> </section> <section id="CD011941-sec-0071"> <p><b>UVB</b></p> <p>For irradiation with UVB light, the studies used devices such as Philips (Eindhoven, the Netherlands) 100 Watts TL‐01 lamps. Four studies used only 311 nm narrowband UVB (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>), two studies used only 280 nm to 320 nm broadband UVB (<a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>), and two studies used both (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> reported a 300 nm to 320 nm 'selective phototherapy', which represents a part of the broadband UVB and which has been predominantly in German phototherapy centres. Some studies assessed a so‐called minimal erythema dose (MED) before treatment to determine a starting dose, which might be set at 50% of the MED. The MED was defined as the dose to produce a just‐detectable erythema with sharp borders within 24 hours in some uninvolved and untanned skin areas of 2 cm<sup>2</sup>. The authors of four studies reported mean starting doses from 0.02 J/cm<sup>2</sup> to 0.4 J/cm<sup>2</sup> (<a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>). In general, UVB was applied once a day, three to five days a week, for up to eight weeks, and reaching a maximum number of 15 to 35 applications. </p> </section> <section id="CD011941-sec-0072"> <p><b>Cumulative UVB doses</b></p> <p>Regarding the intervention (salt water bath + UVB), the authors of five studies (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>) reported mean cumulative doses for primarily or only using narrowband UVB from 11.8 J/cm<sup>2</sup> to 50.7 J/cm<sup>2</sup> and the authors of two studies (<a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>) reported mean cumulative doses for only using broadband UVB from 2.7 J/cm<sup>2</sup> to 7.2 J/cm<sup>2</sup>. Regarding the comparator (UVB alone), the authors of seven studies reported mean cumulative doses for narrowband UVB from 12.5 J/cm<sup>2</sup> to 41.3 J/cm<sup>2</sup>and for broadband UVB from 2.8 J/cm<sup>2</sup> to 7.2 J/cm<sup>2</sup> (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). One study did not report UVB doses (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>). </p> </section> </section> </section> <section id="CD011941-sec-0073"> <h5 class="title">Outcomes</h5> <section id="CD011941-sec-0074"> <h6 class="title">Primary outcomes</h6> <section id="CD011941-sec-0075"> <p><b>Psoriasis area and severity index (PASI)‐75</b></p> <p>Between‐participant data </p> <p>Two of six studies (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>) reported PASI‐75. </p> <p>Four of six studies (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>) reported aggregate data on PASI, such as mean PASI and PASI‐50, but did not report PASI‐75 as defined in the inclusion criteria. It is not possible to deduce PASI‐75 from mean PASI or PASI‐50, but it is possible to calculate PASI‐75 if individual data are available. Therefore, we sent e‐mail requests to the authors of the respective studies to send us individual data on PASI. We used the e‐mail addresses provided by recent papers of the authors. If an e‐mail address was no longer active, we sent the request to an e‐mail address provided by the institution that was involved in the study. We sent enquiries to authors of all included studies. Detailed information is provided in <a href="./appendices#CD011941-sec-0152">Appendix 6</a>. We asked for individual patient data on PASI of the studies by <a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>, <a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>, <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>, <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>, <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>, and <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> to enable a calculation of PASI‐75. We did not receive the requested information. </p> <p>Within‐participant data </p> <p>Two of two studies (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>, <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>) reported individual severity scores which are different from PASI, and they consequently did not report PASI‐75. We sent enquiries to authors of all included studies. Detailed information is provided in <a href="./appendices#CD011941-sec-0152">Appendix 6</a>. We asked for individual patient data on PASI of the studies by <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a> and <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a> to enable a calculation of PASI‐75. We did not receive the requested information. </p> </section> <section id="CD011941-sec-0076"> <p><b>Treatment‐related adverse events requiring withdrawal</b></p> <p>Between‐participant data </p> <p>Two of six studies reported treatment‐related adverse events requiring withdrawal (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>). Four of six studies did not report this outcome. </p> <p>Within‐participant data </p> <p>One study (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>) reported this outcome. </p> </section> </section> <section id="CD011941-sec-0077"> <h6 class="title">Secondary outcomes</h6> <p>The included studies did not report outcomes that were predefined as secondary by the present review including Dermatology Life Quality Index (DLQI), Pruritus severity using a visual analogue scale (VAS) from 0 ('no itching') to 100 ('severe itching'), Time to relapse, and Secondary malignancies. </p> </section> </section> </section> <section id="CD011941-sec-0078"> <h4 class="title">Excluded studies</h4> <p>Of 25 potentially relevant records, we excluded 15 records (<a href="#CD011941-fig-0001">Figure 1</a>). One record (<a href="./references#CD011941-bbs1-0003" title="">Studies awaiting classification</a>) is awaiting classification and is described in the <a href="./references#CD011941-sec-0164" title="">Characteristics of studies awaiting classification</a> table. The reason for exclusion of 15 records (<a href="./references#CD011941-bbs1-0002" title="">Excluded studies</a>) are described in the <a href="./references#CD011941-sec-0163" title="">Characteristics of excluded studies</a> table and are based on: </p> <p> <ul id="CD011941-list-0013"> <li> <p>not intervention of interest (n = 6): Dead Sea bathing and sun exposure; geothermal sea bathing + UVB; sulphurous thermal spring water, bath not followed by UVB consistently; lagoon bathing followed by UVB; oral retinoid added to bath and UVB; and UVB but not salt water baths; </p> </li> <li> <p>not study type of interest (n = 9): systematic review (n = 5); single‐arm study (n = 2); nonsystematic review (n = 2). </p> </li> </ul> </p> </section> <section id="CD011941-sec-0079"> <h4 class="title">Studies awaiting classification</h4> <p><a href="./references#CD011941-bbs2-0024" title="NCT02713711. Effectiveness of artificial balneotherapy, phototherapy and artificial balneophototherapy in the treatment of psoriasis. clinicaltrials.gov/ct2/show/NCT02713711 Date first received: 10 March 2016. ">NCT02713711</a> randomised 24 adult participants with psoriasis in a single‐centre study in Chile. The number of participants correspond to the two treatment groups of interest. The intervention was salt bath followed by artificial UVB. The comparator was artificial UVB only. The study was sponsored by Universidad Catolica del Maule, Chile. This study is completed and the authors have submitted the manuscript. At the present time, the manuscript has not been accepted for publication. Thus, the results of the outcomes are not available yet (correspondence with study author shown in <a href="./appendices#CD011941-sec-0152">Appendix 6</a>). </p> </section> </section> <section id="CD011941-sec-0080"> <h3 class="title">Risk of bias in included studies</h3> <p>The risk of bias table in <a href="./references#CD011941-sec-0162" title="">Characteristics of included studies</a> provides details of each item of the risk of bias tool for randomised controlled trials. <a href="#CD011941-fig-0002">Figure 2</a> and <a href="#CD011941-fig-0003">Figure 3</a> provide an overview. </p> <div class="figure" id="CD011941-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011941-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011941-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011941-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011941-sec-0081"> <h4 class="title">Allocation</h4> <p>The authors of six studies clearly described an adequate random sequence generation and an adequate concealment of the allocation, which was judged as low risk of bias (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). In the other two studies, selection bias from random sequence generation and an adequate concealment of the allocation was judged as unclear risk of bias (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>). </p> </section> <section id="CD011941-sec-0082"> <h4 class="title">Blinding</h4> <p>The authors of five studies reported that they did not blind investigators and patients and we judged a high risk of performance bias (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). A further study did not report this topic so we also judged it as high risk of performance bias (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>). One study reported the issue of blinding, but patients and nurses were not blinded (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>). As physicians may have been blinded, we judged an unclear risk of performance bias. One other study reported partial blinding of people or limbs, and we judged an unclear risk of bias (<a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>). </p> <p>Most of the studies tried to blind the persons involved in outcome assessment, but this could not be achieved in all cases. We judged a low risk of detection bias in four studies as the assessors were presumably unaware of patients' treatment assignments (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). We judged an unclear risk in two studies as the blinding was tried but was not achieved (<a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>). The authors of one study did not report this topic so we considered it high risk of detection bias (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>) . In addition, one study was considered at high risk as blinding was not implemented (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>). </p> </section> <section id="CD011941-sec-0083"> <h4 class="title">Incomplete outcome data</h4> <p>Concerning three studies, we were unsure whether a rather low proportion of dropouts or a high proportion of dropouts but the application of an intention‐to‐treat analysis may have affected the outcome (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). Therefore, we judged them at unclear risk of attrition bias. We judged attrition bias as high risk in three studies (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>) as a considerable number of patient data could not be used in the analysis. In two studies, we did not identify attrition bias and they were judged low risk of bias (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>). </p> </section> <section id="CD011941-sec-0084"> <h4 class="title">Selective reporting</h4> <p>No protocol was available for any included study. Thus, we searched for inconsistencies within the reporting of the article. We did not identify a selective reporting issue and judged all eight studies at unclear risk of reporting bias (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). </p> </section> <section id="CD011941-sec-0085"> <h4 class="title">Other potential sources of bias</h4> <p>We did not identify a substantial source of other bias from the information available in the reports; hence, we judged all eight included studies at unclear risk of other sources of bias due to insufficient information available to make a full assessment (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>). </p> </section> </section> <section id="CD011941-sec-0086"> <h3 class="title" id="CD011941-sec-0086">Effects of interventions</h3> <p>See: <a href="./full#CD011941-tbl-0001"><b>Summary of findings 1</b> Salt bath + UVB compared with UVB alone for chronic plaque psoriasis</a> </p> <section id="CD011941-sec-0087"> <h4 class="title">Comparison 1: Salt bath plus UVB versus other treatment without UVB</h4> <section id="CD011941-sec-0088"> <h5 class="title">Primary outcomes</h5> <section id="CD011941-sec-0089"> <h6 class="title">PASI‐75 response</h6> <p>We did not identify appropriate data.</p> </section> <section id="CD011941-sec-0090"> <h6 class="title">Treatment‐related adverse events requiring withdrawal</h6> <p>We did not identify appropriate data.</p> </section> </section> <section id="CD011941-sec-0091"> <h5 class="title">Secondary outcomes</h5> <section id="CD011941-sec-0092"> <h6 class="title">Dermatology Life Quality Index (DLQI)</h6> <p>We did not identify appropriate data.</p> </section> <section id="CD011941-sec-0093"> <h6 class="title">Pruritus severity using a visual analogue scale (VAS) from 0 ('no itching') to 100 ('severe itching') </h6> <p>We did not identify appropriate data.</p> </section> <section id="CD011941-sec-0094"> <h6 class="title">Time to relapse</h6> <p>We did not identify appropriate data.</p> </section> <section id="CD011941-sec-0095"> <h6 class="title">Secondary malignancies</h6> <p>We did not identify appropriate data.</p> </section> </section> <section id="CD011941-sec-0096"> <h5 class="title">Not predefined outcomes</h5> <p>We identified outcomes reported in the eight included studies that were not predefined by the current review. These outcomes should not have an impact on the conclusion. Nevertheless, the respective results should be reported to provide a broader picture of the results reported in the various studies. </p> <section id="CD011941-sec-0097"> <h6 class="title">PASI‐50 response (between‐participant data)</h6> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> reported the proportion of participants who achieved a 50% or more reduction in their Psoriasis Area and Severity Index score (PASI‐50) from baseline (<a href="#CD011941-tbl-0005">Table 4</a>). <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> reported proportions of PASI‐50 of the intervention group salt bath + UVB that were similar to those of the comparator group psoralen bath + UVA (<a href="#CD011941-tbl-0005">Table 4</a>). The difference between treatment groups was not statistically significant. </p> <div class="table" id="CD011941-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">PASI‐50 (between‐participant data)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Time point</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Proportion</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Proportion</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Session 18 (six weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86% (68 of 79)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71/79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54% (38 of 71)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>&lt; 0.001</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Session 18 (six weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73% (58 of 79)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64/83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50% (32 of 64)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.0053</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Eight weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>74.9% (224 of 299)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>285/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.7% (173 of 285)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.0003</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>305/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.4% (239 of 305)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3369</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>: Estimated by review authors using Easy Fisher Exact Test Calculator (<a href="./references#CD011941-bbs2-0088" title="StangroomJ . Easy Fisher Exact Test Calculator for 2 x 2 Contingency Table. www.socscistatistics.com/tests/Default.aspx (accessed 29 June 2018).">Social Science Statistics 2018</a>); statistically signifiant P values (P &lt; 0.05) in bold font. </p> <p>A/R: number of analysed/randomised people; n.r.: not reported; PASI‐50: Participants have achieved a 50% or more reduction in their Psoriasis Area and Severity Index score from baseline; UVB: artificial ultraviolet B light </p> </div> </div> </section> <section id="CD011941-sec-0098"> <h6 class="title">PASI (between‐participant data)</h6> <p>We did not identify appropriate data.</p> </section> <section id="CD011941-sec-0099"> <h6 class="title">Clearance of psoriatic lesions (within‐participant data)</h6> <p>We did not identify appropriate data.</p> </section> <section id="CD011941-sec-0100"> <h6 class="title">Treatment‐related adverse events</h6> <p>All eight included studies reported on treatment‐related adverse events (<a href="#CD011941-tbl-0006">Table 5</a>) such as dermatitis solaris, phototoxic reaction, erythema, burning, stinging, itching, itchy papular eruption, edema, and blisters. The relationship of adverse events with study interventions was classified as definitive, possible, or unlikely by the study authors. We extracted only adverse events which were classified as definitive or possible. We limited the reporting on statistically significant results. </p> <div class="table" id="CD011941-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Treatment‐related adverse events</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Type</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Events</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Type</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Events</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16/20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burning erythema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17/20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burning erythema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dermatitis solaris</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71/79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dermatitis solaris</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 x phototoxic reaction</p> <p>1 × burning/stinging</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53/83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2x phototoxic reaction</p> <p>3x dermatitis solaris</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4861</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41/60 arms or legs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 x itching,</p> <p>2 x stinging</p> <p>1 x itchy papular eruption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41/60 arms or legs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>&lt; 0.0257</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10/10 elbows</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10/10 elbows</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>'Definite' or 'probable' events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>179/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>'Definite' or 'probable' events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0943</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24/24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Itching and burning in most cases</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21/21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Itching and burning in most cases</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3661</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p>284/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Phototoxic reactions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>252/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Phototoxic reactions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.894</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>266/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Phototoxic reactions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0809</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>297/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Phototoxic reactions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.0072</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Grade IV or V erythemas</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>252/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade IV or V erythemas</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.6263</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>266/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade IV or V erythemas</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>297/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade IV or V erythemas</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7252</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oedema<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oedema<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blisters<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blisters<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a.</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>: Estimated by review authors using Easy Fisher Exact Test Calculator (<a href="./references#CD011941-bbs2-0088" title="StangroomJ . Easy Fisher Exact Test Calculator for 2 x 2 Contingency Table. www.socscistatistics.com/tests/Default.aspx (accessed 29 June 2018).">Social Science Statistics 2018</a>); statistically signifiant P values (P &lt; 0.05) in bold font. </p> <p><sup>2</sup>: <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> reported seven patients who developed edema and four who developed blisters, but the adverse events were not linked to a treatment group. </p> <p>A/R: number of analyzed/randomized people or limbs; n.a.: not applicable; n.r.: not reported; UVA: artivicial ultraviolet A light; UVB: artificial ultraviolet B light </p> </div> </div> <section id="CD011941-sec-0101"> <p><b>Between‐participant data</b></p> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> reported 33 events in 284 assessed participants after exposure of salt water + UVB versus 16 events in 297 participants after psoralen bath + UVA. The difference between the treatment groups was statistically significant (P = 0.0072) in favour of psoralen bath + UVA. The 49 events were phototoxic reactions. </p> </section> <section id="CD011941-sec-0102"> <p><b>Within‐participant data</b></p> <p>We did not identify statistically significant results.</p> </section> </section> <section id="CD011941-sec-0103"> <h6 class="title">Treatment‐related severe adverse events</h6> <section id="CD011941-sec-0104"> <p><b>Between‐participant data</b></p> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> reported zero events in the intervention group salt bath + UVB and three events (photodermatitis, photodermatitis, and malignant melanoma) and three events in the comparator group psoralen bath + UVA (<a href="#CD011941-tbl-0007">Table 6</a>). The difference between the treatment groups was not statistically significant. </p> <div class="table" id="CD011941-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Treatment‐related serious adverse events</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Type</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Events</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Type</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Events</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>284/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>n.a.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>252/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>266/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 x photodermatitis;</p> <p>1 x</p> <p>exacerbation as guttate</p> <p>psoriasis;</p> <p>1 alcohol problem</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1125</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>297/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 x photodermatitis;</p> <p>1 x malignant melanoma<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2491</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>: Estimated by review authors using Easy Fisher Exact Test Calculator (<a href="./references#CD011941-bbs2-0088" title="StangroomJ . Easy Fisher Exact Test Calculator for 2 x 2 Contingency Table. www.socscistatistics.com/tests/Default.aspx (accessed 29 June 2018).">Social Science Statistics 2018</a>); statistically signifiant P values (P &lt; 0.05) in bold font. </p> <p><sup>2</sup>: <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> provided detailed information on the malignant melanoma case: "A malignant melanoma was diagnosed after the eighth irradiation. Queries at the trial site disclosed that an 'atypical nevus' had already been detected by a dermatologist 17 months before study enrollment. Furthermore, it is very unlikely that the tumor had progressed during the short period of 2 weeks." Though, a relationship between study intervention and event was judged as possible, we did not separately include the case as a secondary malignancy. </p> <p>A/R: number of analysed/randomised people; n.a.: not applicable; UVA: artificial ultraviolet A light; UVB: artificial ultraviolet B light </p> </div> </div> </section> <section id="CD011941-sec-0105"> <p><b>Within‐participant data</b></p> <p>We did not identify appropriate data.</p> </section> </section> <section id="CD011941-sec-0106"> <h6 class="title">Patient‐reported outcomes</h6> <p>The authors of four studies (<a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>) reported patient‐reported outcomes (<a href="#CD011941-tbl-0008">Table 7</a>). We did not consider the self‐administered Psoriasis Area and Severity Index (S‐PASI), the patients' self‐rated analogue to the clinician‐rated PASI, which is scored and interpreted as the PASI (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>). We did not consider the short form of the questionnaire on experience with skin complaints (SF‐QES) reported by <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>, because the test of statistical significance on change scores were applied across four different treatment groups only. </p> <div class="table" id="CD011941-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Patient‐reported outcomes</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>HRQL</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Measure</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change of index</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change of index</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global rating of disease severity by patients. Mean change of score (standard deviation) baseline to end of treatment (maximum 6 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.9 (24.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.4 (24.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" baseline to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32.2 (27.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.5 (25.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" baseline to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.5 (27.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.3 (27.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global rating of treatment effect by patients. Mean (standard deviation) score at end of treatment (maximum 6 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81.2 (19.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.5 (27.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global rating of tolerability by patients. Mean (standard deviation) score at end of treatment (maximum 6 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87.4 (12.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87.4 (12.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Self‐administered PASI (S‐PASI). Number of participants with reduction of S‐PASI by 50% or more (%) at end of treatment (maximum 6 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45 (58)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61/83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 (39)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.04</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" at 3 months.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40 (56)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54/83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 (44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" at 6 months.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 (45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46/83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 (50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.70</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoriasis disability index at eight weeks on session 35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/183<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐18.3% ((22.3 ‐ 27.3) / 27.3)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/184<sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐15.2%%</p> <p>((25.6 ‐ 30.2) / 30.2)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" at one month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐26.1% ((20.2 ‐ 27.3) / 27.3)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐20.5%%</p> <p>((24.0 ‐ 30.2) / 30.2)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" at six months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐30.0% ((19.1 ‐ 27.3) / 27.3)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐23.5%%</p> <p>((23.1 ‐ 30.2) / 30.2)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sickness impact profile at eight weeks on session 35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐19.0%</p> <p>((4.7 ‐ 5.8) / 5.8)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐10.7%</p> <p>((5.0 ‐ 5.6) / 5.6)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" at one month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐20.7%</p> <p>((4.6 ‐ 5.8) / 5.8)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐8.9%</p> <p>((5.1 ‐ 5.6) / 5.6)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" at six months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐31.0%</p> <p>((4.0 ‐ 5.8) / 5.8)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐21.4%</p> <p>((4.4 ‐ 5.6) / 5.6)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Improvement of physical complaints of Freiburg Life Quality Assessment on session 35 (eight weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+16.7% ((2.8 ‐ 2.4) / 2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+8.3% ((2.6 ‐ 2.4) / 2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>&lt;0.001</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global health total of Freiburg Life Quality Assessment on session 35 (eight weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+37.5% ((3.3 ‐ 2.4) / 2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+8.3% ((2.6 ‐ 2.4) / 2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.007</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global health skin only of Freiburg Life Quality Assessment on session 35 (eight weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+100.0% ((4.8 ‐ 2.4) / 2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+54.2% ((3.7 ‐ 2.4) / 2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.001</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global impression of therapy: very good or good on session 35 (eight weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>&lt;0.001</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global impression of therapy: very bad or bad on session 35 (eight weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30.4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>&lt;0.001</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life index determined on a 10‐cm analog scale on day 21 (three weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24/24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐60%<sup>6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21/21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐50%<sup>6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global rating of disease severity by patients. Mean change of score (standard deviation) baseline to 2, 4, and 6 weeks or to end of treatment (maximum 8 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.3 (26.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>270/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.5 (26.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.3 (26.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>285/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28.1 (29.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.3 (26.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>305/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.2 (27.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global rating of treatment effect by patients. Mean (standard deviation) score at 2, 4, and 6 weeks or at end of treatment (maximum 8 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.8 (21.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>270/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.0 (27.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.8 (21.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>285/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.3 (29.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.8 (21.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>305/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82.9 (22.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global rating of tolerability by patients. Mean (standard deviation) score at 2, 4, and 6 weeks or at end of treatment (maximum 8 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85.1 (16.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>270/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.8 (21.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85.1 (16.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>285/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82.3 (19.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85.1 (16.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>305/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88.6 (16.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>7</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short Form of the Questionnaire on Experience with Skin complaints (SF‐QES). Change scores did not differ significantly between groups (P = 0.47). Overall median improvement was ‐0.14 (25th to 75th percentile, ‐1.27 to 0.00; n = 1107 participants). Assessment at 2, 4, and 6 weeks or at end of treatment (maximum 8 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.47</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Self‐administered PASI (S‐PASI). Number of participants with reduction of S‐PASI by 50% or more (%) at 2, 4, and 6 weeks or at end of treatment (maximum 8 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>286/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>217 (75.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>258/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>134 (51.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>&lt;0.001</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>286/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>217 (75.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>266/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>174 (65.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.009</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>286/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>217 (75.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>292/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>237 (81.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.13</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>: P values reported by study </p> <p><sup>2</sup>: <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> and <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>. Global ratings on on disease severity, treatment effect, and tolerability using 100‐mm visual analog scales. Positive change scores indicated improvement, higher scores at the end of treatment indicated better effectivenes or tolerability. </p> <p><sup>3</sup>: 183 patients were randomised to Salt bath + UVB. Data from 144 people were analysed and the data from the following 39 patients were not analysed: Three people did not start treatment; one person was not available for second PASI; early withdrawal concerned 35 people; see figure 1 of the article by <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>. </p> <p><sup>4</sup>: 184 patients were randomised to UVB only. Data from 106 patients were analysed and the data from the following 78 patients were not analysed: Five people did not start treatment; two people were not available for second PASI; early withdrawal concerned 71 patients; see figure 1 of the article by <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>. This figure states that 137 patients participated in the follow‐up six months after treatment. However, the same figure also states that only 106 participants were treated through to the end of treatment at session 35 which equals eight weeks after start of treatment. We suppose that this might be a spelling error. </p> <p><sup>5</sup>: <i>Psoriasis disability index</i> or <i>Sickness impact profile</i> change from baseline as a proportion from baseline as reported by <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> and calculated by review authors using the following formula: ((session 35 ‐ baseline) / baseline). The data show a better improvement in the Salt bath + UVB group compared to the UVB group for all six analyses, though, it is not clear whether the differences are statistically significant. </p> <p><sup>6</sup>: Quality of life index change from baseline as a proportion from baseline as reported and calculated by <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> using the following formula: ((day 21 ‐ day 0) / day 0). The data show a decrease of quality of life index for both treatment groups, however, the quality of life index was not defined by the study and it is not clear whether the changes actually mean impairment or improvement. </p> <p><sup>7</sup>: <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>: The Short Form of the Questionnaire on Experience with Skin complaints (SF‐QES) consists of 4 subscales scored from 0 to 4. One scale has an inverse effect on the underlying construct. Total score, defined as the sum of all subscales, can range from −4 to +12. Higher scores indicate a higher level of stigmatisation feelings. </p> <p><sup>8</sup>: <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>: The Self‐administered PASI (S‐PASI) was operationalized in the same way as the PASI (reduction of S‐PASI or involved body surface area by 50% or more). The S‐PASI proved to be a reliable, valid, and responsive outcome measure. The S‐PASI is scored and interpreted in the same way as the PASI. </p> <p>A/R: number of analysed/randomised people; n.r.: not reported; not stat signif: not statistically significant; PUVA: psoralen and ultraviolet A light; UVB: artificial ultraviolet B light </p> </div> </div> <section id="CD011941-sec-0107"> <p><b>Between‐participant data</b></p> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> reported global ratings on disease severity, treatment effect, and tolerability using 100‐mm visual analogue scales (VAS) (<a href="#CD011941-tbl-0008">Table 7</a>). The numbers of assessed participants in the intervention group salt bath + UVB versus the comparator group psoralen bath + UVA were not specified. Statistical significance was not tested. </p> </section> <section id="CD011941-sec-0108"> <p><b>Within‐participant data</b></p> <p>We did not identify appropriate data.</p> </section> </section> </section> </section> <section id="CD011941-sec-0109"> <h4 class="title">Comparison 2: Salt bath plus UVB versus other treatment with UVB or UVB only</h4> <p>Please see <a href="./full#CD011941-tbl-0001">summary of findings Table 1</a>. </p> <section id="CD011941-sec-0110"> <h5 class="title">Primary outcomes</h5> <section id="CD011941-sec-0111"> <h6 class="title">PASI‐75 response</h6> <section id="CD011941-sec-0112"> <p><b>Between‐participant data</b></p> <p><a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a> and <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> stated the proportion of participants who achieved PASI‐75 at time points between six to eight weeks after start of treatment (<a href="#CD011941-tbl-0009">Table 8</a>). <a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a> found a higher proportion of PASI‐75 in the intervention group salt bath + UVB versus the comparator group UVB only. The difference between treatment groups was statistically significant (P = 0.0044) in favour of salt bath. <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> also found a higher proportion of PASI‐75 with salt bath + UVB versus UVB only. However, the difference between treatment groups was not statistically significant (P = 0.0632). We pooled the data of both studies and estimated a risk ratio of 1.71 (95% CI 1.24 to 2.35; P = 0.0009; 278 participants; two studies; low‐certainty evidence); <a href="./references#CD011941-fig-0007" title="">Analysis 1.1</a>; <a href="#CD011941-fig-0004">Figure 4</a>) which favours salt bath + UVB. Please note that due to the nature of this measurement (that is, the number of patients with a PASI‐75), a high event rate is favourable. </p> <div class="table" id="CD011941-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">PASI‐75 (between‐participant data)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Time point</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Achieved; Failed</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Achieved; Failed</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a><sup>2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>session 18 (six weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58% (45 of 78); 42% (33 of 78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66/79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33% (22 of 66); 67% (44 of 66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0044</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>session 18 (six weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39% (29 of 74); 1% (45 of 74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60/83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23% (14 of 60); 77% (46 of 60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0632</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>: Estimated by review authors using Easy Fisher Exact Test Calculator (<a href="./references#CD011941-bbs2-0088" title="StangroomJ . Easy Fisher Exact Test Calculator for 2 x 2 Contingency Table. www.socscistatistics.com/tests/Default.aspx (accessed 29 June 2018).">Social Science Statistics 2018</a>); statistically signifiant P values (P &lt; 0.05) in bold font. </p> <p><sup>2</sup>: <a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a> and <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> classified the data as results from secondary analysis. </p> <p><sup>3</sup>: We identified a spelling error <a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>: the spelling concerning the heading 'PASI‐75' in table 2 should be 'PASI‐75' instead of 'PASI‐50'. </p> <p>A/R: number of analysed/randomised people or limbs; UVA: artificial ultraviolet A light; UVB: artificial ultraviolet B light </p> </div> </div> <div class="figure" id="CD011941-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Saline+UVB versus UVB, outcome: 1.1 PASI‐75 response." data-id="CD011941-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Saline+UVB versus UVB, outcome: 1.1 PASI‐75 response.</p> </div> </div> </div> </section> <section id="CD011941-sec-0113"> <p><b>Within‐participant data</b></p> <p>We did not identify appropriate data.</p> </section> </section> <section id="CD011941-sec-0114"> <h6 class="title">Treatment‐related adverse events requiring withdrawal</h6> <section id="CD011941-sec-0115"> <p><b>Between‐participant data</b></p> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> and <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> stated the proportion of participants who had treatment‐related adverse events requiring withdrawal (<a href="#CD011941-tbl-0010">Table 9</a>). The differences between treatment groups in both studies were not statistically significant. We pooled the data of the two studies and calculated a risk ratio of 0.96 (95% CI 0.35 to 2.64; P = 0.94; 404 participants; two studies; low‐certainty evidence); <a href="./references#CD011941-fig-0008" title="">Analysis 1.2</a>; <a href="#CD011941-fig-0005">Figure 5</a>). The result did not favour any treatment. </p> <div class="table" id="CD011941-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Treatment‐related adverse events requiring withdrawal</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Time point</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Type and (number) of events</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Type and (number) of events</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>eight weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58/60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>severe itch immediately after Dead Sea salt soaks (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58/60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>inadequate response to phototherapy and conversion to psoralen bath + UVA (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>session 35 (eight weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.sp. (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>179/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.sp. (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3795</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>three weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24/24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>skin irritation (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21/21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>skin irritation (0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2364</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>: Estimated by review authors using Easy Fisher Exact Test Calculator (<a href="./references#CD011941-bbs2-0088" title="StangroomJ . Easy Fisher Exact Test Calculator for 2 x 2 Contingency Table. www.socscistatistics.com/tests/Default.aspx (accessed 29 June 2018).">Social Science Statistics 2018</a>); statistically signifiant P values (P &lt; 0.05) in bold font. </p> <p>A/R: number of analysed/randomised people or limbs; n.r.: not reported; n.sp.: not specified; UVA: artificial ultraviolet A light; UVB: artificial ultraviolet B light </p> </div> </div> <div class="figure" id="CD011941-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Saline + UVB versus UVB, outcome: 1.2 Treatment‐related adverse events requiring withdrawal (between participants)." data-id="CD011941-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Saline + UVB versus UVB, outcome: 1.2 Treatment‐related adverse events requiring withdrawal (between participants). </p> </div> </div> </div> </section> <section id="CD011941-sec-0116"> <p><b>Within‐participant data</b></p> <p><a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a> reported one event with salt bath + UVB and two events with UVB only (<a href="./references#CD011941-fig-0009" title="">Analysis 1.3</a>; <a href="#CD011941-fig-0006">Figure 6</a>). The result did not favour any treatment; low‐certainty evidence. </p> <div class="figure" id="CD011941-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Saline + UVB versus UVB, outcome: 1.3 Treatment‐related adverse events requiring withdrawal (within participants)." data-id="CD011941-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Saline + UVB versus UVB, outcome: 1.3 Treatment‐related adverse events requiring withdrawal (within participants). </p> </div> </div> </div> </section> </section> </section> <section id="CD011941-sec-0117"> <h5 class="title">Secondary outcomes</h5> <section id="CD011941-sec-0118"> <h6 class="title">Dermatology Life Quality Index (DLQI)</h6> <p>We did not identify appropriate data.</p> </section> <section id="CD011941-sec-0119"> <h6 class="title">Pruritus severity using a visual analogue scale (VAS) from 0 ('no itching') to 100 ('severe itching') </h6> <p>We did not identify appropriate data.</p> </section> <section id="CD011941-sec-0120"> <h6 class="title">Time to relapse</h6> <p>We did not identify appropriate data.</p> </section> <section id="CD011941-sec-0121"> <h6 class="title">Secondary malignancies</h6> <p>We did not identify appropriate data.</p> </section> </section> <section id="CD011941-sec-0122"> <h5 class="title">Not predefined outcomes</h5> <p>We identified outcomes reported in the eight included studies that were not predefined by the current review. These outcomes should not have an impact on the conclusion. Nevertheless, the respective results should be reported to provide a broader picture of the results reported in the various studies. </p> <section id="CD011941-sec-0123"> <h6 class="title">PASI‐50 response (between‐participant data)</h6> <p><a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>, <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> and <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> reported PASI‐50 (<a href="#CD011941-tbl-0005">Table 4</a>). <a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a> found a higher proportion of PASI‐50 in the intervention group bath + UVB versus the comparator group UVB only. The difference between treatment groups was statistically significant (P &lt; 0.001) in favour of salt bath + UVB. <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> found also a higher proportion of PASI‐50 in the intervention group salt bath + UVB versus the comparator group UVB only. The difference between treatment groups was also statistically significant (P &lt; 0.0053) in favour of salt bath + UVB. <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> found a higher proportion of PASI‐50 in the intervention group salt bath + UVB versus the comparator group tap water + UVB. The difference between treatment groups was again statistically significant (P &lt; 0.0003) in favour of salt bath + UVB. </p> </section> <section id="CD011941-sec-0124"> <h6 class="title">PASI (between‐participant data)</h6> <p><a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>, <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>, <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> reported the change of PASI score from baseline ((day 21 to day 0)/day 0) (<a href="#CD011941-tbl-0011">Table 10</a>). <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> found a greater reduction of PASI in the intervention group salt bath + UVB versus the comparator group UVB only. The difference between treatment groups was statistically significant (P &lt; 0.0001) in favour of salt bath + UVB. <a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a> and <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> reported data on percentage change in PASI for each group with both groups showing a reduction in PASI; however, no formal statistical comparison of the two groups were presented. </p> <div class="table" id="CD011941-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">PASI (between‐participant data)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Time point</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change of PASI<sup>2</sup> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change PASI<sup>2</sup> </b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Session 24 (eight weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16/20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐90% ((1.5 to 14.6)/14.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17/20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐74% ((3.1 to 11.9)/11.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Session 35 (eight weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>179/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐82% ((2.7 to 15.1)/15.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐44% ((8.6 to 15.3)/15.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.0001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Session 15 (three weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24/24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐55%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21/21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐64%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>: P value calculated by study authors. </p> <p><sup>2</sup>: Calculation takes use of the values measured on the following days: (day 21 ‐ day 0)/day 0. </p> <p>A/R: number of analysed/randomised people; n.r.: not reported; PASI: Psoriasis Area and Severity Index score; UVA: artificial ultraviolet B light; UVB: artificial ultraviolet B light </p> </div> </div> </section> <section id="CD011941-sec-0125"> <h6 class="title">Clearance of psoriatic lesions (within‐participant data)</h6> <p><a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a> and <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a> reported various clearance of psoriatic lesions scores (<a href="#CD011941-tbl-0012">Table 11</a>). In both studies, differences in change of scores from baseline were not statistically significant between treatment groups. </p> <div class="table" id="CD011941-tbl-0012"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Clearance of psoriatic lesions scores (within‐participant data)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Score</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Body parts</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>BL</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change of score<sup>2</sup> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>BL</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change of score<sup>2</sup> </b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>scaling, erythema, and induration score measured at 8 months<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>arms or legs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐63% ((2.5 to 6.8)/6.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐63% ((2.5 to 6.8)/6.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"not significant"</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>five‐point severity score measured after 30 treatments (time point n.r.)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>elbows</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐68% ((2.5 to 7.9)/7.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐69% ((2.4‐7 to 8)/7.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"not significant"</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>: statistical significance reported by study authors </p> <p><sup>2</sup>: Calculation takes use of the values measured on the following weeks: (week 8 ‐ week 0)/week 0. </p> <p><sup>3</sup>: <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>: numerals deduced from the line chart shown in figure 1 of the article. </p> <p>A/R: number of analysed/randomised units; BL: baseline score; n.r.: not reported</p> </div> </div> </section> <section id="CD011941-sec-0126"> <h6 class="title">Treatment‐related adverse events</h6> <section id="CD011941-sec-0127"> <p><b>Between‐participant data</b></p> <p>We did not identify statistically significant results.</p> </section> <section id="CD011941-sec-0128"> <p><b>Within‐participant data</b></p> <p><a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a> reported six events in 41 assessed arms or legs after exposure of salt bath + UVB versus zero events after exposure of UVB only. The difference between the treatment groups was statistically significant (P &lt; 0.0257) in favour of no treatment. The six events in the intervention arm included three times itching, two times stinging, and one time itchy papular eruption. </p> </section> </section> <section id="CD011941-sec-0129"> <h6 class="title">Treatment‐related severe adverse events</h6> <section id="CD011941-sec-0130"> <p><b>Between‐participant data</b></p> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> reported zero events in the intervention group salt bath + UVB and three events (photodermatitis, exacerbation as guttate psoriasis, and alcohol problem) in the comparator group tap water + UVB (<a href="#CD011941-tbl-0007">Table 6</a>). <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> also reported zero events in the comparator group UVB only. The difference between the treatment groups was not statistically significant. </p> </section> <section id="CD011941-sec-0131"> <p><b>Within‐participant data</b></p> <p>We did not identify appropriate data.</p> </section> </section> <section id="CD011941-sec-0132"> <h6 class="title">Patient‐reported outcomes</h6> <p>The authors of four studies (<a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>) reported patient‐reported outcomes (<a href="#CD011941-tbl-0008">Table 7</a>). We did not consider the self‐administered Psoriasis Area and Severity Index (S‐PASI), the patients' self‐rated analogue to the clinician‐rated PASI, which is scored and interpreted as the PASI (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>). We did not consider the short form of the questionnaire on experience with skin complaints (SF‐QES) reported by <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>, because the test of statistical significance on change scores were applied across four different treatment groups only. </p> <section id="CD011941-sec-0133"> <p><b>Between‐participant data</b></p> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> reported global ratings on disease severity, treatment effect, and tolerability using 100 mm visual analogue scales (<a href="#CD011941-tbl-0008">Table 7</a>). The numbers of assessed participants in the intervention group salt water + UVB versus the comparator group UVB only were not specified. Statistical significance was not tested. </p> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> reported a change of the Freiburg Life Quality Assessment for the three parts physical complaints, global health total, and global health skin only (<a href="#CD011941-tbl-0008">Table 7</a>). The data showed improvement in both treatment groups with analyses conducted at the time point session 35 equivalent to six weeks after start of treatment. The results showed statistically significantly better improvement in the intervention group salt bath + UVB versus the comparator group UVB only, which favours salt bath + UVB. </p> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> reported a change from baseline for the psoriasis disability index and the sickness impact profile for the intervention group salt bath + UVB group versus the comparator group UVB only (<a href="#CD011941-tbl-0008">Table 7</a>). Statistical significance was not tested. </p> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> reported the proportion of global impression of therapy (very good or good) as well as global impression of therapy (very bad or bad) (<a href="#CD011941-tbl-0008">Table 7</a>). The differences between the intervention group salt bath + UVB versus the comparator group UVB only were statistically significant, which favours salt bath + UVB. </p> <p><a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> reported a change from baseline for the quality of life index for the intervention group salt bath + UVB versus the comparator group UVB only (<a href="#CD011941-tbl-0008">Table 7</a>). Statistical significance was not tested. </p> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> reported global ratings on disease severity, treatment effect, and tolerability using 100‐mm visual analogue scales (<a href="#CD011941-tbl-0008">Table 7</a>). The numbers of assessed participants in the intervention group salt bath + UVB versus the comparator group tap water + UVB versus the comparator group UVB only were not specified. Statistical significance was not tested. </p> </section> <section id="CD011941-sec-0134"> <p><b>Within‐participant data</b></p> <p>We did not identify appropriate data.</p> </section> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011941-sec-0135" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011941-sec-0135"></div> <section id="CD011941-sec-0136"> <h3 class="title" id="CD011941-sec-0136">Summary of main results</h3> <p>Our review evaluated the current state of evidence on the efficacy of the following:</p> <p> <ul id="CD011941-list-0014"> <li> <p>Indoor salt bath + ultraviolet B (UVB) versus other treatment without UVB (comparison one); </p> </li> <li> <p>Indoor salt bath + UVB versus other treatment + UVB or UVB only (comparison two).</p> </li> </ul> </p> <p>We included eight randomised controlled trials (RCTs) on chronic plaque psoriasis. With respect to predefined outcomes, comparison one was not reported by any included study. With respect to predefined outcomes, comparison two was reported by five included studies. </p> <p>Concerning the primary outcome Psoriasis Area and Severity Index (PASI‐75) response, two between‐participant studies randomised participants to the intervention group salt bath + UVB or to the comparator group UVB only and found that salt bath + UVB may improve psoriasis (low‐certainty evidence) (<a href="./full#CD011941-tbl-0001">summary of findings Table 1</a>). </p> <p>Concerning the primary outcome treatment‐related adverse events requiring withdrawal, two other between‐participant studies also randomised participants to the intervention group salt bath + UVB or to the comparator group UVB only and found that there may be little to no difference between the groups with regard to this outcome (low‐certainty evidence) (<a href="./full#CD011941-tbl-0001">summary of findings Table 1</a>). One of the studies reported skin irritation; the other did not specify the type of adverse events reported by the participants. One within‐participant study (paired right/left comparison) randomised skin areas to the intervention group salt bath + UVB or to the comparator group UVB only and found that there may be little to no difference between the groups with regard to this outcome (low‐certainty evidence). The study reported one event with the salt bath + UVB group (severe itch immediately after Dead Sea salt soaks), and two events with the UVB only group (inadequate response to phototherapy and conversion to psoralen bath + ultraviolet A (UVA)). </p> <p>None of the predefined secondary outcomes of this review were reported in any of the included studies (Dermatology Life Quality Index (DLQI), pruritus severity using a visual analogue scale (VAS), time to relapse, or secondary malignancies). </p> <p>The reporting of our pre‐specified outcomes was either non‐existent or limited, with a maximum of two studies reporting a given outcome. The two trials that contributed data for the primary efficacy outcome did not blind their outcome assessors and were conducted by the same group: one of the two trials was funded by the German Spas Association, but the other trial did not state a funding source. </p> </section> <section id="CD011941-sec-0137"> <h3 class="title" id="CD011941-sec-0137">Overall completeness and applicability of evidence</h3> <p>Seven of the eight included studies were published in 2007 or earlier, and we can assume that the majority of patients were treated 10 to 20 years ago. Nonetheless, we presume that the principle treatment procedures might not deviate considerably from the current practice. </p> <p>The primary outcome PASI‐75 was reported in two out of six between‐participant studies (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>), but not in the two within‐participant studies. </p> <p>The primary outcome treatment‐related adverse events requiring withdrawal was reported in two other between‐participant studies (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>), and in one within‐participant study (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>). Out of eight studies, the primary efficacy outcome (PASI‐75 for two different data types) was reported by only two studies. </p> <p>Out of eight studies, the primary adverse event outcome (treatment‐related adverse events requiring withdrawal for two different data types) were reported by only two between‐participant studies and only one within‐participant study. None of the predefined secondary outcomes were reported, so there were no patient‐reported outcomes. For one of the two comparisons, none of the predefined outcomes were reported, so there is no evidence to assess at all for half of what was of interest. </p> <p>Ultraviolet B phototherapy might pose a risk of carcinogenesis, especially of squamous cell carcinoma, and thus the cumulative exposure time should be controlled (<a href="./references#CD011941-bbs2-0032" title="ChangPL , HsiehYH , WangCC , JulianaMM , TsurutaY , TimaresL , et al. Osteopontin facilitates ultraviolet B-induced squamous cell carcinoma development. Journal of Dermatological Science2014;75(2):121-32. [PMID: 24888687]">Chang 2014</a>; <a href="./references#CD011941-bbs2-0036" title="deGruijlFR . p53 mutations as a marker of skin cancer risk: comparison of UVA and UVB effects. Experimental Dermatology2002;11(Suppl 1):37-9. [PMID: 12444958]">de Gruijl 2002</a>). The studies included in the present review lack long‐term observation and secondary neoplasia was not addressed. </p> <p>All studies were conducted by non‐academic institutions that build their business on the evaluated treatments. Therefore, a financial conflict of interest might be present in most, if not all of the included studies. Five of the eight studies were conducted in Germany. This preference might be the result of a lasting culture‐specific increase of supply in the past or of a supplier‐induced demand in recent times. </p> <p>Key issues are that most trials conducted did not contribute data to the primary outcomes and the primary efficacy outcome data all come from two small unblinded trials conducted by a single group of investigators. There was no information for the primary or secondary outcomes on salt water baths + UVB versus no UVB, which is a key comparison. </p> </section> <section id="CD011941-sec-0138"> <h3 class="title" id="CD011941-sec-0138">Quality of the evidence</h3> <p>To accommodate events in the analysis of the primary outcome PASI‐75, we used the number of people that reached PASI‐75. We downgraded the certainty of evidence by two levels for this outcome (low certainty of evidence). We downgraded one level because of study limitations (risk of bias). Due to lack of blinding, we judged a high risk of performance bias. We downgraded one level because of high probability of publication bias. Six studies included in the review did not contribute to the primary outcome. The two studies that did contribute data (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>) were conducted by the same sponsor. It should be acknowledged that some studies tried to blind outcome assessment and assessed if the blinding could be realised. In general, lack of blinding of outcome assessment contributed to a high risk of bias in most studies. </p> <p>Treatment‐related adverse events requiring withdrawal was also used as primary outcome. We downgraded the certainty of evidence by two levels for this outcome (low certainty of evidence). We downgraded one level because of study limitations (risk of bias). Due to lack of blinding, we judged a high bias of performance bias. We downgraded one level because of high probability of publication bias. Five studies included in the review did not contribute to the primary outcome. Three studies did contribute data, two between‐participant studies (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>) and one within‐participant study (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>). </p> <p>In general, the reporting did not facilitate a clear and instant understanding. The variety in outcome reporting reduced the pooling of data considerably. Many data are not eligible for meta‐analysis, which may create a selection bias within the review. The authors of four studies (<a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a>; <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>; <a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>) did not report a participant flow diagram. Acknowledging the study limitations in the reporting of the two primary outcomes, we judge an unclear internal validity. Secondary outcomes of this review were not measured by any of the included studies; therefore, we were unable to determine the certainty of evidence for these outcomes. </p> </section> <section id="CD011941-sec-0139"> <h3 class="title" id="CD011941-sec-0139">Potential biases in the review process</h3> <p>We conducted a comprehensive search for studies including a search for ongoing studies. The search was broad and sensitive; thus, the risk of not detecting a relevant study is very small. We did not make any post‐hoc analysis decisions after seeing the data. Only two studies reported PASI‐75, and only two studies reported treatment‐related adverse events requiring withdrawal, but we retained the predefined primary outcomes. We tried to access individual study data to complement missing information. Although, we rephrased the name of both outcomes, this did not actually affect the planned concept, but enabled clarification. Subsequently, we assume that there were no relevant departures from protocol that could be potential sources of bias. The restriction to treatment‐related adverse events instead of extracting all adverse events probably reduced the number of events included in the analyses. It is not fully clear if this modification caused or prevented bias. </p> </section> <section id="CD011941-sec-0140"> <h3 class="title" id="CD011941-sec-0140">Agreements and disagreements with other studies or reviews</h3> <p>The Ontario Health Technology Assessment (<a href="./references#CD011941-bbs2-0052" title="Health Quality Ontario. Ultraviolet phototherapy management of moderate-to-severe plaque psoriasis: an evidence-based analysis. Ontario Health Technology Assessment Series2009;9(27):1-66. [PMID: 23074532]">Health Quality Ontario 2009</a>) included four RCTs in a systematic review that are also included in the present review (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>; <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>): quote "The purpose of this evidence based analysis was to determine the effectiveness and safety of ultraviolet phototherapy for moderate‐to‐severe plaque psoriasis. " The authors concluded that quote "Spa salt water baths prior to phototherapy did increase short term clinical response of moderate‐to‐severe plaque psoriasis but did not decrease cumulative ultraviolet irradiation dose" and judged that there was high‐quality and adequate study evidence for this statement. Clinical response was defined as an improvement in physical signs and secondary psychological effects as well as reduction in inflammation and control of skin shedding. </p> <p>In 2004, the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) was commissioned by the Federal Joint Committee (Gemeinsamer Bundesausschuss; G‐BA) to conduct an evaluation of the benefits and harms of different types of balneophototherapy. The systematic literature search was conducted separately for asynchronous and synchronous balneophototherapy in the databases MEDLINE, Embase and CENTRAL (in each case: coverage until March 2006). In the final report (full report in German: <a href="./references#CD011941-bbs2-0058" title="Institute for Quality and Efficiency in Health Care (IQWiG). Balneo-phototherapy, Final report, Commission N04-04 [Balneophototherapie, Abschlussbericht, Auftrag N04-04, Version 1.0, Stand 21 Dezember 2006, Datum des Auftrags 18 Dezember 2004, veröffentlicht 02 Januar 2007]. www.iqwig.de/de/projekte-ergebnisse/projekte/nichtmedikamentoese-verfahren/n04-04-balneophototherapie.1199.html (accessed 15 June 2019).">IQWiG 2006a</a>; executive summary in English: <a href="./references#CD011941-bbs2-0059" title="Institute for Quality and Efficiency in Health Care (IQWiG). Balneo-phototherapy: Executive summary of final report N04-04, Version 1.0, Created: 21 December 2006 (Translation of the executive summary of the final report “Balneophototherapie”). www.ncbi.nlm.nih.gov/books/NBK84168/ (accessed 15 June 2019).">IQWiG 2006b</a>), three types of balneophototherapy were evaluated. </p> <p>1. Asynchronous bath‐PUVA (psoralen plus UVA) compared with UVB only (or tap water bath + UVB) </p> <p> <ul id="CD011941-list-0015"> <li> <p>Intervention and comparator do not match the inclusion criteria of the present review (not intervention of interest) </p> </li> </ul> </p> <p>2. Asynchronous salt bath + UVB compared with UVB only (or tap water bath + UVB)</p> <p> <ul id="CD011941-list-0016"> <li> <p>Intervention and comparator match comparison 2</p> </li> <li> <p>Three included RCTs: the so‐called "<a href="./references#CD011941-bbs2-0030" title="Berufsverband der Deutschen Dermatologen (BVDD). Final report on the clinical efficacy of outpatient balneophototherapy for psoriasis. A multicenter, open, randomized-controlled comparative study. Short title: BP-BVDD [Abschlussbericht zum klinischen Wirksamkeitsnachweis der ambulanten Balneophototherapie für die Psoriasis. Eine multizentrische, offene, randomisiert-kontrollierte Vergleichsstudie. Studienkurztitel: BP-BVDD (Balneo-Phototherapie des Berufs-Verbands der Deutschen Dermatologen)]. Bad Elster: Forschungsinstitut für Balneologie und Kurortwissenschaft2004.">BP‐BVDD‐Studie 2004</a>", <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>, and <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> </p> </li> <li> <p>Conclusion: Salt bath + UVB has an additional benefit compared to UVB only (and also compared to tap water bath + UVB) </p> </li> </ul> </p> <p>3. Synchronous balneophototherapy (Dead Sea salt bath + UVB) compared with UVB only</p> <p> <ul id="CD011941-list-0017"> <li> <p>Intervention and comparator match comparison 2</p> </li> <li> <p>A single RCT: the so‐called "<a href="./references#CD011941-bbs2-0092" title="ARGE der KKV Bayern. Final Report: Actively controlled, randomized, multi-center Phase III study demonstrating the efficacy of synchronous balneo-phototherapy (sBPT) in the treatment of psoriasis vulgaris [Abschlussbericht: Aktiv kontrollierte, randomisierte, multi-zentrische Phase III Studie zum Nachweis der Wirksamkeit der synchronen Balneo-Phototherapie (sBPT) bei der Behandlung von Psoriasis vulgaris]. München: Arbeitsgemeinschaft (ARGE) der Krankenkassenverbände (KKV) in Bayern2006.">TOMESA_PV‐Studie 2006</a>" </p> </li> <li> <p>Conclusion: Dead Sea salt bath + UVB has an additional benefit compared to UVB only</p> </li> </ul> </p> <p>The two studies <a href="./references#CD011941-bbs2-0030" title="Berufsverband der Deutschen Dermatologen (BVDD). Final report on the clinical efficacy of outpatient balneophototherapy for psoriasis. A multicenter, open, randomized-controlled comparative study. Short title: BP-BVDD [Abschlussbericht zum klinischen Wirksamkeitsnachweis der ambulanten Balneophototherapie für die Psoriasis. Eine multizentrische, offene, randomisiert-kontrollierte Vergleichsstudie. Studienkurztitel: BP-BVDD (Balneo-Phototherapie des Berufs-Verbands der Deutschen Dermatologen)]. Bad Elster: Forschungsinstitut für Balneologie und Kurortwissenschaft2004.">BP‐BVDD‐Studie 2004</a> and <a href="./references#CD011941-bbs2-0092" title="ARGE der KKV Bayern. Final Report: Actively controlled, randomized, multi-center Phase III study demonstrating the efficacy of synchronous balneo-phototherapy (sBPT) in the treatment of psoriasis vulgaris [Abschlussbericht: Aktiv kontrollierte, randomisierte, multi-zentrische Phase III Studie zum Nachweis der Wirksamkeit der synchronen Balneo-Phototherapie (sBPT) bei der Behandlung von Psoriasis vulgaris]. München: Arbeitsgemeinschaft (ARGE) der Krankenkassenverbände (KKV) in Bayern2006.">TOMESA_PV‐Studie 2006</a> are not publicly available. Thus, of the eight studies included in the present review, only two published studies were considered by <a href="./references#CD011941-bbs2-0058" title="Institute for Quality and Efficiency in Health Care (IQWiG). Balneo-phototherapy, Final report, Commission N04-04 [Balneophototherapie, Abschlussbericht, Auftrag N04-04, Version 1.0, Stand 21 Dezember 2006, Datum des Auftrags 18 Dezember 2004, veröffentlicht 02 Januar 2007]. www.iqwig.de/de/projekte-ergebnisse/projekte/nichtmedikamentoese-verfahren/n04-04-balneophototherapie.1199.html (accessed 15 June 2019).">IQWiG 2006a</a>. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G‐BA), the highest decision‐making body concerning the distribution of the Statutory Health Insurance funds in Germany, decided that indoor salt water baths followed by artificial ultraviolet B (UVB) light for patients with severe and medium severe chronic plaque psoriasis can be reimbursed not only by hospitals, but also by practices (<a href="./references#CD011941-bbs2-0042" title="Gemeinsamer Bundesausschuss (G-BA). Richtlinie Methoden vertragsärztliche Versorgung (Balneophototherapie) Beschlussdatum: 13.03.2008. www.g-ba.de/informationen/beschluesse/645 (accessed 1 October 2015).">G‐BA 2008</a>). </p> <p><a href="./references#CD011941-bbs2-0082" title="RoosS , HammesS , OckenfelsHM . Psoriasis. Natural versus artificial balneophototherapy [Psoriasistherapie. Künstliche versus natürliche Photosole]. Hautarzt2010;61(8):683-90. [PMID: 20607200]">Roos 2010</a> suggested in a nonsystematic review to offer also natural balneophototherapy (Dead Sea climatotherapy) to patients though it would include additional travel and accommodation costs. <a href="./references#CD011941-bbs2-0012" title="ChenX , YangM , ChengY , LiuGJ , ZhangM . Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD009481.pub2]">Chen 2013</a> did not detect a difference in the effect between those phototherapy variations in a Cochrane Review. These results supported our decision that we did not differentiate between broad‐band ultraviolet B, narrow‐band ultraviolet B, mixed type irradiations, and psoralen bath + UVA in the present review. In a systematic review on ultraviolet based therapy for psoriasis, <a href="./references#CD011941-bbs2-0025" title="AlmutawaF , AlnomairN , WangY , HamzaviI , LimHW . Systematic review of UV-based therapy for psoriasis. American Journal of Clinical Dermatology2013;14(2):87-109. [PMID: 23572293]">Almutawa 2013</a>, in contrast, did report some differences among the phototherapy variations: quote "As a monotherapy, PUVA was more effective than NB‐UVB, and NB‐UVB was more effective than BB‐UVB and bath PUVA in the treatment of adults with moderate to severe plaque‐type psoriasis, based on clearance as an end point." </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011941-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/urn:x-wiley:14651858:media:CD011941:CD011941-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011941-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_t/tCD011941-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011941-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/urn:x-wiley:14651858:media:CD011941:CD011941-FIG-02" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011941-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_t/tCD011941-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011941-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/urn:x-wiley:14651858:media:CD011941:CD011941-FIG-03" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011941-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_t/tCD011941-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011941-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/urn:x-wiley:14651858:media:CD011941:CD011941-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Saline+UVB versus UVB, outcome: 1.1 PASI‐75 response." data-id="CD011941-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_t/tCD011941-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Saline+UVB versus UVB, outcome: 1.1 PASI‐75 response.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011941-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/urn:x-wiley:14651858:media:CD011941:CD011941-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Saline + UVB versus UVB, outcome: 1.2 Treatment‐related adverse events requiring withdrawal (between participants)." data-id="CD011941-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_t/tCD011941-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Saline + UVB versus UVB, outcome: 1.2 Treatment‐related adverse events requiring withdrawal (between participants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011941-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/urn:x-wiley:14651858:media:CD011941:CD011941-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Saline + UVB versus UVB, outcome: 1.3 Treatment‐related adverse events requiring withdrawal (within participants)." data-id="CD011941-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_t/tCD011941-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Saline + UVB versus UVB, outcome: 1.3 Treatment‐related adverse events requiring withdrawal (within participants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011941-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/urn:x-wiley:14651858:media:CD011941:CD011941-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Saline+UVB versus UVB, Outcome 1: PASI‐75 response" data-id="CD011941-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_t/tCD011941-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Saline+UVB versus UVB, Outcome 1: PASI‐75 response</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/references#CD011941-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011941-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/urn:x-wiley:14651858:media:CD011941:CD011941-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Saline+UVB versus UVB, Outcome 2: Treatment‐related adverse events requiring withdrawal (between participant)" data-id="CD011941-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_t/tCD011941-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Saline+UVB versus UVB, Outcome 2: Treatment‐related adverse events requiring withdrawal (between participant) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/references#CD011941-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011941-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/urn:x-wiley:14651858:media:CD011941:CD011941-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Saline+UVB versus UVB, Outcome 3: Treatment‐related adverse events requiring withdrawal (within participant)" data-id="CD011941-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_t/tCD011941-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Saline+UVB versus UVB, Outcome 3: Treatment‐related adverse events requiring withdrawal (within participant) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/references#CD011941-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/media/CDSR/CD011941/image_n/nCD011941-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011941-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Salt bath + UVB compared with UVB alone for chronic plaque psoriasis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Salt bath + UVB compared with UVB alone for chronic plaque psoriasis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients with chronic plaque psoriasis<br/><b>Setting:</b> indoor clinic or spa<br/><b>Intervention:</b> salt bath + UVB<br/><b>Comparison:</b> UVB alone </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks (95% CI)*</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect</b> <br/><b>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Number of participants</b> <br/><b>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of evidence</b> <br/><b>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk<sup>c</sup> </b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>PASI‐75 (number of participants with event) 6 to 8 weeks after start of treatment</b> </p> </th> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.71</p> <p>(1.24 to 2.35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>278</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The event was defined as achieving a 75% or more reduction in PASI score from baseline.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>285 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>487 per 1000</p> <p>(353 to 669)</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Treatment‐related adverse events requiring withdrawal (number of participants withdrawing) 3 to 8 weeks after the start of treatment<sup>d</sup> </b> </p> </th> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.96 (0.35 to 2.64)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>404</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The event was defined as dropping out of the study because of treatment‐related complications.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34 per 1000</p> <p>(12 to 92)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>PASI:</b> Psoriasis Area and Severity Index. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> We downgraded the certainty of evidence by two levels for this outcome. We downgraded one level because of study limitations (risk of bias). Due to lack of blinding, we judged a high bias of performance bias. We downgraded one level because of high probability of publication bias. The only two between‐participant studies that did contribute data on salt bath + UVB versus UVB alone (<a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>; <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a>) to this outcome were conducted by the same sponsor. </p> <p><sup>b</sup> We downgraded the certainty of evidence by two levels for this outcome. We downgraded one level because of study limitations (risk of bias). Due to lack of blinding, we judged a high risk of performance bias. We downgraded one level because of high probability of publication bias. There were only two between‐participant studies (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>; <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>) that contributed data on salt bath + UVB versus UVB alone to this outcome. </p> <p><sup>c</sup> The assumed risk is based on the mean number of events across the control groups. Calculation regarding PASI‐75 response: Number of events: 22 + 14 = 36, total number of participants: 66 + 60 = 126, risk per 1000: 36 / 126 * 1000 = 285. </p> <p><sup>d</sup> Two between‐participant studies (<a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>, <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a>) reported seven events with salt bath + UVB and seven events with UVB only. One additional within‐participant study (<a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>) reported one event with salt bath + UVB and two events with UVB only. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Salt bath + UVB compared with UVB alone for chronic plaque psoriasis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011941-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Psoriasis Area and Severity Index (PASI)</span></div> <tbody> <tr> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Section</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Area involved</b> </p> </th> <th align="center" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Severity</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Item</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Factor</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Item</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Factor</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Item</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Clinical signs</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Factor</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Head</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0, 1, 2, 3, 4, 5, or 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sum of clinical signs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Erythema (redness)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0, 1, 2, 3, or 4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 10%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Induration (thickness)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0, 1, 2, 3, or 4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10% to &lt; 30%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Desquamation (scaling)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0, 1, 2, 3, or 4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30% to &lt; 50%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50% to &lt; 70%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70% to &lt; 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90% to 100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Arms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trunk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Legs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Subtotal</p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Section factor *area factor* sum of clinical signs factor</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Sum of subtotals; range 0 to 72</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>According to <a href="./references#CD011941-bbs2-0041" title="FredrikssonT , PetterssonU . Severe psoriasis--oral therapy with a new retinoid. Dermatologica1978;157(4):238-44. [PMID: 357213]">Fredriksson 1978</a>. Online calculator available (<a href="./references#CD011941-bbs2-0035" title="CortiM , CortiM . Psoriasis Area Severity Index (PASI) Calculator (1.7.1) 2009. pasi.corti.li (accessed 22 July 2014).">Corti 2009</a>). Instructions: multiply section factor with area involved factor and multiply with sum of clinical signs factor; repeat for all four sections and add up all four subtotals. The items and corresponding factors regarding the area involved and the severity are exemplified for the section item 'head' and are not shown for the other section items 'arms', 'trunk', and 'legs'. Severity of clinical signs range from none (zero) to maximum (four). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Psoriasis Area and Severity Index (PASI)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011941-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Dermatology Life Quality Index (DLQI) questionnaire</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Question</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Answer options</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how itchy, sore, painful, or stinging has your skin been?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how embarrassed or self‐conscious have you been because of your skin? </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how much has your skin interfered with you going shopping or looking after your home or garden? </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> <p>Not relevant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how much has your skin influenced the clothes you wear?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> <p>Not relevant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how much has your skin affected any social or leisure activities?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> <p>Not relevant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how much has your skin made it difficult for you to do any sport?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> <p>Not relevant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, has your skin prevented you from working or studying?</p> <p>(If "No", over the last week, how much has your skin been a problem at work or studying?)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> <p>No</p> <p>Not relevant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how much has your skin created problems with your partner or any of your close friends? </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> <p>Not relevant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how much has your skin caused any sexual difficulties?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> <p>Not relevant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over the last week, how much of a problem has the treatment for your skin been, for example, by making your home messy or by taking up time? </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very much</p> <p>A lot</p> <p>A little</p> <p>Not at all</p> <p>Not relevant</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>The aim of the Dermatology Life Quality Index (DLQI) questionnaire is to measure how much the life of adults has been affected by their skin problem over the last week. The DLQI is calculated by summing the score of each question, resulting in a maximum of 30 and a minimum of zero. The higher the score, the more quality of life is impaired. The scoring of each question is as follows: Very much (three), A lot (two), A little (one), Not at all (zero), Not relevant (zero); question seven = Yes (three) to unanswered (zero). </p> <p>Meaning of the total DLQI score: zero to one = no effect at all on patient's life; two to five = small effect on patient's life; six to 10 = moderate effect on patient's life; 11 to 20 = very large effect on patient's life; 21 to 30 = extremely large effect on patient's life. Minimal Clinically Important Difference (MCID) of the DLQI: a change in DLQI score of at least four points is considered clinically important (<a href="./references#CD011941-bbs2-0029" title="BasraMK , FenechR , GattRM , SalekMS , FinlayAY . The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. British Journal of Dermatology2008;159(5):997-1035. [PMID: 18795920]">Basra 2008</a>). </p> <p><a href="./references#CD011941-bbs2-0039" title="FinlayAY , KhanGK . Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clinical &amp; Experimental Dermatology1994;19(3):210-6. [PMID: 8033378]">Finlay 1994</a> developed the DLQI. The following website provides further information and interpretation: <a href="http://www.dermatology.org.uk/quality/quality-life.html" target="_blank">www.dermatology.org.uk</a>. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Dermatology Life Quality Index (DLQI) questionnaire</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011941-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Salt concentrations</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparator</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7 g/L NaCl dissolved in tap water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.7 mg/L psoralen dissolved in tap water</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>250 to 270 g/L NaCl present in natural spring water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no bath</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45 to 120 g/L NaCl present in natural spring water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no bath</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150 g/L Dead Sea salt dissolved in tap water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no bath</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>240 g/L NaCl dissolved in tap water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2 g/L present in tap water</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 g/L Dead Sea salt dissolved in tap water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no bath</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>250 g/L NaCl present in natural sping water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no bath</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>250 g/L NaCL dissolved in tap water</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5 mg/L psoralen dissolved in tap water</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>NaCl: sodium chloride</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Salt concentrations</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011941-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">PASI‐50 (between‐participant data)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Time point</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Proportion</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Proportion</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Session 18 (six weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86% (68 of 79)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71/79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54% (38 of 71)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>&lt; 0.001</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Session 18 (six weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73% (58 of 79)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64/83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50% (32 of 64)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.0053</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Eight weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>74.9% (224 of 299)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>285/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.7% (173 of 285)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.0003</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>305/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.4% (239 of 305)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3369</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>1</sup>: Estimated by review authors using Easy Fisher Exact Test Calculator (<a href="./references#CD011941-bbs2-0088" title="StangroomJ . Easy Fisher Exact Test Calculator for 2 x 2 Contingency Table. www.socscistatistics.com/tests/Default.aspx (accessed 29 June 2018).">Social Science Statistics 2018</a>); statistically signifiant P values (P &lt; 0.05) in bold font. </p> <p>A/R: number of analysed/randomised people; n.r.: not reported; PASI‐50: Participants have achieved a 50% or more reduction in their Psoriasis Area and Severity Index score from baseline; UVB: artificial ultraviolet B light </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">PASI‐50 (between‐participant data)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011941-tbl-0006"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Treatment‐related adverse events</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Type</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Events</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Type</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Events</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16/20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burning erythema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17/20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burning erythema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dermatitis solaris</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71/79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dermatitis solaris</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 x phototoxic reaction</p> <p>1 × burning/stinging</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53/83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2x phototoxic reaction</p> <p>3x dermatitis solaris</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4861</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41/60 arms or legs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 x itching,</p> <p>2 x stinging</p> <p>1 x itchy papular eruption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41/60 arms or legs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>&lt; 0.0257</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10/10 elbows</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10/10 elbows</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>'Definite' or 'probable' events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>179/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>'Definite' or 'probable' events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0943</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24/24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Itching and burning in most cases</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21/21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Itching and burning in most cases</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3661</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p>284/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Phototoxic reactions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>252/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Phototoxic reactions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.894</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>266/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Phototoxic reactions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0809</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>297/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Phototoxic reactions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.0072</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Grade IV or V erythemas</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>252/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade IV or V erythemas</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.6263</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>266/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade IV or V erythemas</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>297/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade IV or V erythemas</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7252</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oedema<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oedema<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blisters<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blisters<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a.</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p><sup>1</sup>: Estimated by review authors using Easy Fisher Exact Test Calculator (<a href="./references#CD011941-bbs2-0088" title="StangroomJ . Easy Fisher Exact Test Calculator for 2 x 2 Contingency Table. www.socscistatistics.com/tests/Default.aspx (accessed 29 June 2018).">Social Science Statistics 2018</a>); statistically signifiant P values (P &lt; 0.05) in bold font. </p> <p><sup>2</sup>: <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> reported seven patients who developed edema and four who developed blisters, but the adverse events were not linked to a treatment group. </p> <p>A/R: number of analyzed/randomized people or limbs; n.a.: not applicable; n.r.: not reported; UVA: artivicial ultraviolet A light; UVB: artificial ultraviolet B light </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Treatment‐related adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011941-tbl-0007"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Treatment‐related serious adverse events</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Type</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Events</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Type</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Events</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>284/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>n.a.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>252/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>266/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 x photodermatitis;</p> <p>1 x</p> <p>exacerbation as guttate</p> <p>psoriasis;</p> <p>1 alcohol problem</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1125</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>297/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 x photodermatitis;</p> <p>1 x malignant melanoma<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2491</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p><sup>1</sup>: Estimated by review authors using Easy Fisher Exact Test Calculator (<a href="./references#CD011941-bbs2-0088" title="StangroomJ . Easy Fisher Exact Test Calculator for 2 x 2 Contingency Table. www.socscistatistics.com/tests/Default.aspx (accessed 29 June 2018).">Social Science Statistics 2018</a>); statistically signifiant P values (P &lt; 0.05) in bold font. </p> <p><sup>2</sup>: <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a> provided detailed information on the malignant melanoma case: "A malignant melanoma was diagnosed after the eighth irradiation. Queries at the trial site disclosed that an 'atypical nevus' had already been detected by a dermatologist 17 months before study enrollment. Furthermore, it is very unlikely that the tumor had progressed during the short period of 2 weeks." Though, a relationship between study intervention and event was judged as possible, we did not separately include the case as a secondary malignancy. </p> <p>A/R: number of analysed/randomised people; n.a.: not applicable; UVA: artificial ultraviolet A light; UVB: artificial ultraviolet B light </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Treatment‐related serious adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011941-tbl-0008"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Patient‐reported outcomes</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>HRQL</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Measure</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change of index</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change of index</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global rating of disease severity by patients. Mean change of score (standard deviation) baseline to end of treatment (maximum 6 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.9 (24.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.4 (24.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" baseline to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32.2 (27.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.5 (25.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" baseline to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.5 (27.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.3 (27.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global rating of treatment effect by patients. Mean (standard deviation) score at end of treatment (maximum 6 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81.2 (19.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.5 (27.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global rating of tolerability by patients. Mean (standard deviation) score at end of treatment (maximum 6 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87.4 (12.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87.4 (12.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Self‐administered PASI (S‐PASI). Number of participants with reduction of S‐PASI by 50% or more (%) at end of treatment (maximum 6 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45 (58)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61/83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 (39)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.04</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" at 3 months.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40 (56)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54/83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 (44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" at 6 months.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 (45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46/83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 (50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.70</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoriasis disability index at eight weeks on session 35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/183<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐18.3% ((22.3 ‐ 27.3) / 27.3)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/184<sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐15.2%%</p> <p>((25.6 ‐ 30.2) / 30.2)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" at one month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐26.1% ((20.2 ‐ 27.3) / 27.3)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐20.5%%</p> <p>((24.0 ‐ 30.2) / 30.2)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" at six months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐30.0% ((19.1 ‐ 27.3) / 27.3)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐23.5%%</p> <p>((23.1 ‐ 30.2) / 30.2)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sickness impact profile at eight weeks on session 35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐19.0%</p> <p>((4.7 ‐ 5.8) / 5.8)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐10.7%</p> <p>((5.0 ‐ 5.6) / 5.6)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" at one month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐20.7%</p> <p>((4.6 ‐ 5.8) / 5.8)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐8.9%</p> <p>((5.1 ‐ 5.6) / 5.6)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>" at six months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐31.0%</p> <p>((4.0 ‐ 5.8) / 5.8)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r./184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐21.4%</p> <p>((4.4 ‐ 5.6) / 5.6)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Improvement of physical complaints of Freiburg Life Quality Assessment on session 35 (eight weeks) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+16.7% ((2.8 ‐ 2.4) / 2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+8.3% ((2.6 ‐ 2.4) / 2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>&lt;0.001</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global health total of Freiburg Life Quality Assessment on session 35 (eight weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+37.5% ((3.3 ‐ 2.4) / 2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+8.3% ((2.6 ‐ 2.4) / 2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.007</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global health skin only of Freiburg Life Quality Assessment on session 35 (eight weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+100.0% ((4.8 ‐ 2.4) / 2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+54.2% ((3.7 ‐ 2.4) / 2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.001</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global impression of therapy: very good or good on session 35 (eight weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>&lt;0.001</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global impression of therapy: very bad or bad on session 35 (eight weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30.4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>&lt;0.001</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life index determined on a 10‐cm analog scale on day 21 (three weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24/24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐60%<sup>6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21/21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐50%<sup>6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global rating of disease severity by patients. Mean change of score (standard deviation) baseline to 2, 4, and 6 weeks or to end of treatment (maximum 8 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.3 (26.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>270/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.5 (26.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.3 (26.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>285/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28.1 (29.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.3 (26.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>305/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.2 (27.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global rating of treatment effect by patients. Mean (standard deviation) score at 2, 4, and 6 weeks or at end of treatment (maximum 8 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.8 (21.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>270/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.0 (27.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.8 (21.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>285/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.3 (29.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.8 (21.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>305/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82.9 (22.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global rating of tolerability by patients. Mean (standard deviation) score at 2, 4, and 6 weeks or at end of treatment (maximum 8 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85.1 (16.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>270/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.8 (21.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85.1 (16.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>285/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82.3 (19.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>299/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85.1 (16.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>305/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88.6 (16.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>7</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short Form of the Questionnaire on Experience with Skin complaints (SF‐QES). Change scores did not differ significantly between groups (P = 0.47). Overall median improvement was ‐0.14 (25th to 75th percentile, ‐1.27 to 0.00; n = 1107 participants). Assessment at 2, 4, and 6 weeks or at end of treatment (maximum 8 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.47</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Self‐administered PASI (S‐PASI). Number of participants with reduction of S‐PASI by 50% or more (%) at 2, 4, and 6 weeks or at end of treatment (maximum 8 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>286/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>217 (75.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>258/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>134 (51.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>&lt;0.001</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>286/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>217 (75.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>266/301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>174 (65.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.009</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a><sup>8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>286/310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>217 (75.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>292/321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>237 (81.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.13</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>1</sup>: P values reported by study </p> <p><sup>2</sup>: <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> and <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>. Global ratings on on disease severity, treatment effect, and tolerability using 100‐mm visual analog scales. Positive change scores indicated improvement, higher scores at the end of treatment indicated better effectivenes or tolerability. </p> <p><sup>3</sup>: 183 patients were randomised to Salt bath + UVB. Data from 144 people were analysed and the data from the following 39 patients were not analysed: Three people did not start treatment; one person was not available for second PASI; early withdrawal concerned 35 people; see figure 1 of the article by <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>. </p> <p><sup>4</sup>: 184 patients were randomised to UVB only. Data from 106 patients were analysed and the data from the following 78 patients were not analysed: Five people did not start treatment; two people were not available for second PASI; early withdrawal concerned 71 patients; see figure 1 of the article by <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a>. This figure states that 137 patients participated in the follow‐up six months after treatment. However, the same figure also states that only 106 participants were treated through to the end of treatment at session 35 which equals eight weeks after start of treatment. We suppose that this might be a spelling error. </p> <p><sup>5</sup>: <i>Psoriasis disability index</i> or <i>Sickness impact profile</i> change from baseline as a proportion from baseline as reported by <a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> and calculated by review authors using the following formula: ((session 35 ‐ baseline) / baseline). The data show a better improvement in the Salt bath + UVB group compared to the UVB group for all six analyses, though, it is not clear whether the differences are statistically significant. </p> <p><sup>6</sup>: Quality of life index change from baseline as a proportion from baseline as reported and calculated by <a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> using the following formula: ((day 21 ‐ day 0) / day 0). The data show a decrease of quality of life index for both treatment groups, however, the quality of life index was not defined by the study and it is not clear whether the changes actually mean impairment or improvement. </p> <p><sup>7</sup>: <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>: The Short Form of the Questionnaire on Experience with Skin complaints (SF‐QES) consists of 4 subscales scored from 0 to 4. One scale has an inverse effect on the underlying construct. Total score, defined as the sum of all subscales, can range from −4 to +12. Higher scores indicate a higher level of stigmatisation feelings. </p> <p><sup>8</sup>: <a href="./references#CD011941-bbs2-0008" title="SchienerA , BrockowT , WeimerM , HochdorferB , FreitagL , SalzerB , et al. Balneo-phototherapy. Superiority can no longer be denied. Journal of Plastic Dermatology2006;2(2):39-41. [CENTRAL: CN-00613244] SchienerR , BrockowT , FrankeA , SalzerB , PeterRU , ReschKL . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Archives of Dermatology2007;143(5):586-96. [CENTRAL: CN-00589110] [PMID: 17519218]">Schiener 2007</a>: The Self‐administered PASI (S‐PASI) was operationalized in the same way as the PASI (reduction of S‐PASI or involved body surface area by 50% or more). The S‐PASI proved to be a reliable, valid, and responsive outcome measure. The S‐PASI is scored and interpreted in the same way as the PASI. </p> <p>A/R: number of analysed/randomised people; n.r.: not reported; not stat signif: not statistically significant; PUVA: psoralen and ultraviolet A light; UVB: artificial ultraviolet B light </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Patient‐reported outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011941-tbl-0009"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">PASI‐75 (between‐participant data)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Time point</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Achieved; Failed</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Achieved; Failed</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a><sup>2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>session 18 (six weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58% (45 of 78); 42% (33 of 78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66/79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33% (22 of 66); 67% (44 of 66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0044</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>session 18 (six weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39% (29 of 74); 1% (45 of 74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60/83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23% (14 of 60); 77% (46 of 60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0632</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>1</sup>: Estimated by review authors using Easy Fisher Exact Test Calculator (<a href="./references#CD011941-bbs2-0088" title="StangroomJ . Easy Fisher Exact Test Calculator for 2 x 2 Contingency Table. www.socscistatistics.com/tests/Default.aspx (accessed 29 June 2018).">Social Science Statistics 2018</a>); statistically signifiant P values (P &lt; 0.05) in bold font. </p> <p><sup>2</sup>: <a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a> and <a href="./references#CD011941-bbs2-0003" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV2007;21(8):1027-37. [CENTRAL: CN-00618957] [PMID: 17714121]">Brockow 2007b</a> classified the data as results from secondary analysis. </p> <p><sup>3</sup>: We identified a spelling error <a href="./references#CD011941-bbs2-0002" title="BrockowT , SchienerR , FrankeA , ReschKL , PeterRU . A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. Journal of Alternative and Complementary Medicine2007;13(7):725-32. [CENTRAL: CN-00620063] [PMID: 17931065]">Brockow 2007a</a>: the spelling concerning the heading 'PASI‐75' in table 2 should be 'PASI‐75' instead of 'PASI‐50'. </p> <p>A/R: number of analysed/randomised people or limbs; UVA: artificial ultraviolet A light; UVB: artificial ultraviolet B light </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">PASI‐75 (between‐participant data)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011941-tbl-0010"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Treatment‐related adverse events requiring withdrawal</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Time point</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Type and (number) of events</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Type and (number) of events</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>eight weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58/60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>severe itch immediately after Dead Sea salt soaks (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58/60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>inadequate response to phototherapy and conversion to psoralen bath + UVA (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>session 35 (eight weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.sp. (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>179/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.sp. (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3795</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>three weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24/24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>skin irritation (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21/21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>skin irritation (0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2364</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>1</sup>: Estimated by review authors using Easy Fisher Exact Test Calculator (<a href="./references#CD011941-bbs2-0088" title="StangroomJ . Easy Fisher Exact Test Calculator for 2 x 2 Contingency Table. www.socscistatistics.com/tests/Default.aspx (accessed 29 June 2018).">Social Science Statistics 2018</a>); statistically signifiant P values (P &lt; 0.05) in bold font. </p> <p>A/R: number of analysed/randomised people or limbs; n.r.: not reported; n.sp.: not specified; UVA: artificial ultraviolet A light; UVB: artificial ultraviolet B light </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Treatment‐related adverse events requiring withdrawal</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011941-tbl-0011"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">PASI (between‐participant data)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Time point</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change of PASI<sup>2</sup> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>A/R</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change PASI<sup>2</sup> </b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0001" title="ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. British Journal of Dermatology2001;145(2):352-4. [CENTRAL: CN-00350275] [PMID: 11531811]ArnoldWP , vanAndelP , deHoopD , deJong-TiebenL , Visser-van AndelM . Difference in effectiveness between salt bath and a bath with 8-methoxypsoralene with small spectrum UVB-therapy. Nederlands tijdschrift voor dermatologie en venereologie2000;10:106-7. [CENTRAL: CN-00602286] ">Arnold 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Session 24 (eight weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16/20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐90% ((1.5 to 14.6)/14.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psoralen bath + UVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17/20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐74% ((3.1 to 11.9)/11.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0006" title="KleinA , SchiffnerR , Schiffner-RoheJ , Einsele-KramerB , HeinlinJ , StolzW , et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). Journal of the European Academy of Dermatology and Venereology: JEADV2011;25(5):570-8. [CENTRAL: CN-00802620] [PMID: 20840347]">Klein 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Session 35 (eight weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>179/183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐82% ((2.7 to 15.1)/15.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177/184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐44% ((8.6 to 15.3)/15.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.0001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0007" title="Leaute-LabrezeC , SaillourF , CheneG , CazenaveC , Luxey-BellocqML , SanciaumeC , et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: Lessons from the Salies de Bearn randomized study. Archives of Dermatology2001;137(8):1035-9. [CENTRAL: CN-00356070] [PMID: 11493096]">Leaute‐Labreze 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Session 15 (three weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24/24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐55%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21/21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐64%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.r.</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>1</sup>: P value calculated by study authors. </p> <p><sup>2</sup>: Calculation takes use of the values measured on the following days: (day 21 ‐ day 0)/day 0. </p> <p>A/R: number of analysed/randomised people; n.r.: not reported; PASI: Psoriasis Area and Severity Index score; UVA: artificial ultraviolet B light; UVB: artificial ultraviolet B light </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">PASI (between‐participant data)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011941-tbl-0012"> <div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Clearance of psoriatic lesions scores (within‐participant data)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Score</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Body parts</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Comparators</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value<sup>1</sup> </b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>BL</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change of score<sup>2</sup> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>BL</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change of score<sup>2</sup> </b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>scaling, erythema, and induration score measured at 8 months<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>arms or legs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐63% ((2.5 to 6.8)/6.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐63% ((2.5 to 6.8)/6.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"not significant"</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011941-bbs2-0005" title="GambichlerT , RappS , SengerE , AltmeyerP , HoffmannK . Balneophototherapy of psoriasis: highly concentrated salt water versus tap water -- a randomized, one-blind, right/left comparative study. Photodermatology, Photoimmunology &amp; Photomedicine2001;17(1):22-5. [CENTRAL: CN-00327517] [PMID: 11169172]">Gambichler 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>five‐point severity score measured after 30 treatments (time point n.r.)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>elbows</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salt bath + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐68% ((2.5 to 7.9)/7.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tap water + UVB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐69% ((2.4‐7 to 8)/7.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"not significant"</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p><sup>1</sup>: statistical significance reported by study authors </p> <p><sup>2</sup>: Calculation takes use of the values measured on the following weeks: (week 8 ‐ week 0)/week 0. </p> <p><sup>3</sup>: <a href="./references#CD011941-bbs2-0004" title="DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. British Journal of Dermatology2005;153(3):613-9. [CENTRAL: CN-00529697] [PMID: 16120152]DaweRS , YuleS , CameronH , MoseleyH , IbbotsonSH , FergusonJ . A randomized controlled study of Dead Sea salt balneophototherapy for psoriasis. British Journal of Dermatology2004;151(Suppl 68):104. [CENTRAL: CN-00487817] ">Dawe 2005</a>: numerals deduced from the line chart shown in figure 1 of the article. </p> <p>A/R: number of analysed/randomised units; BL: baseline score; n.r.: not reported</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Clearance of psoriatic lesions scores (within‐participant data)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/full#CD011941-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011941-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Saline+UVB versus UVB</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 PASI‐75 response <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.71 [1.24, 2.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Treatment‐related adverse events requiring withdrawal (between participant) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.35, 2.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Treatment‐related adverse events requiring withdrawal (within participant) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.05, 5.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Saline+UVB versus UVB</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011941.pub2/references#CD011941-tbl-0013">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011941.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011941-note-0021">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011941-note-0018">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011941-note-0020">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD011941-note-0017">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD011941-note-0019">Polski</a> </li> <li class="section-language"> <a class="" href="th#CD011941-note-0016">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011941-note-0015">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011941\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011941\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011941\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011941\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011941\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UiM8QuvV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011941.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011941.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011941.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011941.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011941.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718962850"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011941.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718962854"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011941.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ddd227f991be5',t:'MTc0MDcxODk2My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 